###begin article-title 0
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Nucleocapsid Region of HIV-1 Gag Cooperates with the PTAP and LYPXnL Late Domains to Recruit the Cellular Machinery Necessary for Viral Budding
###end article-title 0
###begin p 1
Conceived and designed the experiments: VD FB. Performed the experiments: VD MPJ GAJ JAJ. Analyzed the data: VD FB. Wrote the paper: FB. Performed electron microscopy experiments: JdlC KN.
###end p 1
###begin p 2
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 734 735 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 802 803 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1467 1468 1467 1468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 182 184 <span type="species:ncbi:103820">NC</span>
###xml 256 261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 433 438 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 455 <span type="species:ncbi:103820">NC</span>
###xml 870 875 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 958 963 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1038 1040 <span type="species:ncbi:103820">NC</span>
###xml 1142 1144 <span type="species:ncbi:103820">NC</span>
###xml 1317 1319 <span type="species:ncbi:103820">NC</span>
HIV-1 release is mediated through two motifs in the p6 region of Gag, PTAP and LYPXnL, which recruit cellular proteins Tsg101 and Alix, respectively. The Nucleocapsid region of Gag (NC), which binds the Bro1 domain of Alix, also plays an important role in HIV-1 release, but the underlying mechanism remains unclear. Here we show that the first 202 residues of the Bro1 domain (Broi) are sufficient to bind Gag. Broi interferes with HIV-1 release in an NC-dependent manner and arrests viral budding at the plasma membrane. Similar interrupted budding structures are seen following over-expression of a fragment containing Bro1 with the adjacent V domain (Bro1-V). Although only Bro1-V contains binding determinants for CHMP4, both Broi and Bro1-V inhibited release via both the PTAP/Tsg101 and the LYPXnL/Alix pathways, suggesting that they interfere with a key step in HIV-1 release. Remarkably, we found that over-expression of Bro1 rescued the release of HIV-1 lacking both L domains. This rescue required the N-terminal region of the NC domain in Gag and the CHMP4 binding site in Bro1. Interestingly, release defects due to mutations in NC that prevented Bro1 mediated rescue of virus egress were rescued by providing a link to the ESCRT machinery via Nedd4.2s over-expression. Our data support a model in which NC cooperates with PTAP in the recruitment of cellular proteins necessary for its L domain activity and binds the Bro1-CHMP4 complex required for LYPXnL-mediated budding.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 502 507 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 717 719 <span type="species:ncbi:103820">NC</span>
###xml 767 772 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 829 831 <span type="species:ncbi:103820">NC</span>
###xml 888 893 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 985 990 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1051 1053 <span type="species:ncbi:103820">NC</span>
###xml 1175 1177 <span type="species:ncbi:103820">NC</span>
###xml 1192 1197 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency virus type 1 (HIV-1) assembles its structural protein Gag into a viral shell at the plasma membrane. Gag is divided into several regions, each with its own distinct function(s). Within the p6 region of Gag, there are two short peptide sequences, called Late (L) domains, that serve to recruit cellular proteins Tsg101 and Alix. In an uninfected cell, these proteins facilitate membrane dynamics during vesicle budding into cellular compartments called endosomes. Upon infection, HIV-1 hijacks these proteins and makes use of the machinery to facilitate viral budding at the plasma membrane. Our study shows that, in addition to binding the p6 region, Alix also interacts with the Nucleocapsid (NC) region of Gag. Importantly, we show that when HIV-1 buds via the Alix-driven pathway, this interaction with NC is essential for recruiting host proteins necessary for HIV-1 release. Moreover, we show that a non-functional fragment of Alix inhibits Tsg101-mediated HIV-1 release in ways similar to those caused by mutations in the NC domain of Gag. Collectively, our findings favor a model in which the p6-located L domain motifs require cooperation with NC to facilitate HIV-1 release.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Swanstrom1">[1]</xref>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Bouamr1">[2]</xref>
###xml 435 438 435 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Bryant1">[3]</xref>
###xml 439 442 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Zhou1">[4]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Freed1">[5]</xref>
###xml 560 563 560 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-GanserPornillos1">[6]</xref>
###xml 642 645 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Campbell1">[7]</xref>
###xml 646 649 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Campbell2">[8]</xref>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Rein1">[9]</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Gottlinger1">[10]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Huang1">[11]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Bieniasz1">[12]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Carter1">[13]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Demirov1">[14]</xref>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Morita1">[15]</xref>
###xml 4 32 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 235 237 <span type="species:ncbi:103820">NC</span>
###xml 569 571 <span type="species:ncbi:103820">NC</span>
The human immunodeficiency virus type I (HIV-1) Gag polyprotein, p55Gag, is the main structural component of viral particles [1]. It carries four distinct domains: the N-terminal Matrix (MA), the central capsid (CA), the Nucleocapsid (NC) and the C-terminal p6 region. MA is responsible for targeting Gag to the plasma membrane for assembly via a bipartite signal composed of a myristic acid moiety and a cluster of basic residues [2],[3],[4]. The CA domain bears regions essential for Gag-Gag multimerization and is the main constituent of the viral core [5],[6]. The NC domain promotes Gag-Gag assembly via its ability to interact with RNA [7],[8],[9]. Viral particle budding from the plasma membrane requires the activity of L domain motifs within p6 [10],[11], which recruit cellular proteins necessary for membrane fission and release [12],[13],[14],[15].
###end p 6
###begin p 7
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Garrus1">[16]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano1">[17]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-VerPlank1">[18]</xref>
###xml 174 175 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Garrus1">[16]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Bouamr2">[22]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Demirov2">[23]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano3">[24]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Stuchell1">[25]</xref>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Babst1">[26]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Katzmann1">[27]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kostelansky1">[28]</xref>
###xml 629 631 629 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ch</italic>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Babst2">[29]</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Babst3">[30]</xref>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Babst4">[31]</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kieffer1">[32]</xref>
###xml 754 758 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Scott1">[33]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-StuchellBrereton1">[34]</xref>
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 254 259 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 554 559 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 846 851 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Two late domains have been identified within the p6 of HIV-1 Gag, the PTAP and LYPXnL motifs. The PTAP motif binds the cellular protein Tsg101 [16],[17],[18] whereas the LYPXnL motif is the docking site for Alix/AIP-1 [19],[20],[21]. Tsg101 functions in HIV-1 budding [16],[22],[23] as a member of the Endosomal Sorting Complex Required for Transport-1 (ESCRT-I) [21],[24],[25], which initiates the sorting of surface proteins into late endosomal compartments known as multivesicular bodies (MVB) [26],[27],[28]. This process is topologically similar to HIV-1 budding and requires the recruitment of ESCRT-III members called the charged-multivesicular body proteins (CHMP) [19],[20],[21],[29] and the activity of VPS4 AAA-type ATPase [21],[30],[31],[32],[33],[34]. The PTAP/Tsg101 driven pathway is considered to be the predominant mechanism for HIV-1 release.
###end p 7
###begin p 8
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano4">[35]</xref>
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Lee1">[36]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Zhai1">[37]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Missotten1">[38]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Vito1">[39]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano5">[40]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Odorizzi1">[41]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Odorizzi2">[42]</xref>
###xml 293 294 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 433 437 433 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Odorizzi1">[41]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Carlton1">[43]</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Morita2">[45]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kim1">[46]</xref>
###xml 531 535 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kim1">[46]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-McMahon1">[48]</xref>
###xml 878 882 878 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 936 937 936 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 943 944 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I</italic>
###xml 954 955 954 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 1003 1004 1003 1004 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Chen1">[49]</xref>
###xml 541 547 <span type="species:ncbi:89151|species:ncbi:4641">banana</span>
###xml 784 789 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 835 840 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 936 942 <span type="species:ncbi:9796">Equine</span>
###xml 968 972 <span type="species:ncbi:11665?1.0">EIAV</span>
The second L domain motif, LYPXnL, binds Alix [19],[20],[21],[35],[36],[37], an ALG-2 interacting host protein [38],[39] presumed to function in endosomal metabolism [40],[41],[42]. Structural studies revealed that Alix is comprised of three distinct domains, an N-terminal Bro1 domain, a LYPXnL binding coiled-coil V domain, and a C-terminal proline rich domain (PRD), which interacts with several cellular factors including Tsg101 [19],[41],[43],[44],[45]. The N-terminal Bro1 domain binds the ESCRT-III CHMP4 proteins [44],[46],[47]. The banana shaped structure of the Bro1 domain [44],[46] suggests a possible role in membrane curvature [48] during the normal function of Alix in both MVB and retroviral budding. Although Alix is currently considered to play a supporting role in HIV-1 release, it was recently shown to facilitate HIV-1 release in absence of the PTAP motif [44],[47]. Furthermore, Alix is sufficient for release of Equine Infectious Anemia Virus (EIAV), which contains only the LYPXnL type L domain motif [20],[44],[47],[49].
###end p 8
###begin p 9
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Hanson1">[50]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Howard1">[51]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Lin1">[52]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Zamborlini1">[53]</xref>
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 295 300 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 581 586 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 765 770 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The ESCRT-III CHMP proteins are recruited by HIV-1 Gag either indirectly, through the Tsg101-PTAP motif interaction, or directly by the V domain of Alix binding to the LYPXnL motif [19],[20],[21]. Recent studies showed that recruitment of CHMP4 proteins by Bro1 is required for Alix function in HIV-1 release [44],[47]. Most recently, it was shown that CHMP4 proteins self-associate into filaments that promote membrane bending away from the cytoplasm [50]. Interestingly, over-expression of dominant negative versions of CHMP proteins induces Class E-like phenotypes and inhibits HIV-1 budding [19],[20],[21],[51],[52],[53]. These studies are consistent with a role for ESCRT-III members, especially the CHMP4b isoform, in facilitating fission events that lead to HIV-1 separation from the plasma membrane.
###end p 9
###begin p 10
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano4">[35]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Mannigel1">[54]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano6">[55]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott1">[56]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack2">[57]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano4">[35]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano6">[55]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott1">[56]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack2">[57]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Parent1">[58]</xref>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack2">[57]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano6">[55]</xref>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 886 890 886 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott1">[56]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang1">[63]</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 371 373 <span type="species:ncbi:103820">NC</span>
###xml 513 515 <span type="species:ncbi:103820">NC</span>
###xml 553 555 <span type="species:ncbi:103820">NC</span>
###xml 677 682 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 718 720 <span type="species:ncbi:103820">NC</span>
###xml 797 802 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 829 831 <span type="species:ncbi:103820">NC</span>
###xml 963 965 <span type="species:ncbi:103820">NC</span>
###xml 976 981 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1098 1100 <span type="species:ncbi:103820">NC</span>
In recent years, multiple studies have suggested that the ability of L domain motifs to facilitate budding and release is context-dependent [35],[54],[55],[56],[57]. This implies that they cooperate with other regions within Gag to achieve efficient viral release [35],[55],[56],[57],[58],[59]. Consistent with this notion, the PTAP motif was shown to cooperate with the NC-p1 regions [57] and also to require p6 residues 15-51, which include the Alix binding site, to function optimally [55]. Most recently, the NC domain of Gag (hereafter also called NC) was found to engage the Bro1 domain of Alix, an interaction that is required for the LYPXnL/Alix pathway to function in HIV-1 release [60]. Mutations within the NC domain or deletion of the entire domain significantly reduce the release of HIV-1 particles even though the NC-deleted Gag retains the ability to assemble particles [56],[61],[62],[63],[64]. Together these observations suggest a role for the NC domain in HIV-1 budding driven by L domain motifs located within the neighboring p6 domain. The temporal and spatial involvement of NC in particle budding and egress, and the extent to which it functions with p6 have not yet been clearly established.
###end p 10
###begin p 11
###xml 359 360 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 981 982 981 982 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 38 40 <span type="species:ncbi:103820">NC</span>
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 207 209 <span type="species:ncbi:103820">NC</span>
###xml 255 257 <span type="species:ncbi:103820">NC</span>
###xml 261 266 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 385 387 <span type="species:ncbi:103820">NC</span>
###xml 588 590 <span type="species:ncbi:103820">NC</span>
###xml 605 607 <span type="species:ncbi:103820">NC</span>
###xml 694 699 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 716 718 <span type="species:ncbi:103820">NC</span>
###xml 812 814 <span type="species:ncbi:103820">NC</span>
###xml 945 947 <span type="species:ncbi:103820">NC</span>
###xml 1059 1064 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The absence of direct evidence for an NC role in HIV-1 budding, and of effective means of interfering with such a function, make it difficult to establish a functional link between p6 Late domain motifs and NC. We used Alix to examine a possible role for NC in HIV-1 budding and identified a small fragment of Bro1 that inhibits both Tsg101/PTAP and Alix/LYPXnL budding pathways in an NC-dependent manner. Over-expression of the full length Bro1 domain rescues budding defects caused by disruption of the PTAP and LYPXnL motifs; rescue requires a CHMP4 binding site in Bro1 and an intact NC. Mutations in NC that prevent Bro1-mediated viral release also inhibit the release of a PTAP-dependent HIV-1 suggesting that NC function is required for both pathways. Interestingly, mutants defective due to mutations in NC can be rescued by providing a link to ESCRT components via a parallel pathway. Collectively, our results support a model in which NC cooperates with the PTAP and LYPXnL motifs in p6 to recruit components of the cellular machinery necessary for HIV-1 budding.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Over-expression of Alix inhibits HIV-1 budding
###end title 13
###begin p 14
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 346 356 346 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s001">Figure S1A</xref>
###xml 429 439 429 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s001">Figure S1A</xref>
###xml 589 599 589 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s001">Figure S1A</xref>
###xml 675 683 675 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g001">Figure 1</xref>
###xml 848 864 836 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g001">Figure 1B and 1C</xref>
###xml 1119 1128 1107 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g001">Figure 1B</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 131 136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 201 206 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 314 319 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 513 518 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 574 579 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 771 776 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 941 946 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 recruits Tsg101 and Alix to bud from the plasma membrane of infected cells. When the Tsg101-driven pathway is not available (HIV-1 PTAP- mutant), over-expression of Alix has been shown to rescue HIV-1 release defects [44],[47]. Titration analysis indicated that the optimal amount of HA-Alix that stimulated HIV-1 PTAP- was relatively low (Figure S1A, lane 3), whereas in contrast, higher amounts failed to rescue release (Figure S1A, lane 5). Interestingly, amounts of HA-Alix that prevented the rescue of HIV-1 PTAP- release also caused a significant decrease in wt HIV-1 release (Figure S1A, lane 9). Further analysis and quantification of this inhibition, shown in Figure 1, demonstrated that over-expression of increasing amounts of HA-Alix potently inhibited HIV-1 exit, as only approximately15% of virus was detected outside the cell (Figure 1B and 1C). Similar results were obtained when this experiment was performed with the HIV-1 strain BH10 (data not shown). Alix over-expression also decreased Gag processing as a modest accumulation of p25CA and other Gag intermediate processing products was seen (Figure 1B).
###end p 14
###begin title 15
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Over-expression of Alix inhibits HIV-1 release.
###end title 15
###begin p 16
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</italic>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 611 616 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Schematic representation of the domain organization of Alix. Bro1: BCK1-like resistance to osmotic shock 1, V: V-shaped domain, PRD: Proline Rich Domain. Numbers indicate positions of amino acid residues. (B) Virus-release assay showing that over-expression of Alix inhibits virus release. 293T cells were transfected with either wild-type (wt) pNL4-3 plasmid alone or with increasing amounts of HA-Alix. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. Gag intermediate products are indicated with (*) symbols. (C) Relative release efficiency of HIV-1 virions upon over-expression of Alix. The release efficiency in presence of Alix (calculated at the highest amount shown in B, lane 4) is relative to the release efficiency of NL4-3 alone, which was arbitrarily set at 100. Error bars indicate the standard deviation from four separate experiments. (D) Transmission Electron Microscopy (TEM) images of thin-sectioned 293T cells transfected with pNL4-3 wt alone (upper left panel) or pNL4-3 wt + Alix (lower left panel and close-ups of regions of interest a, b, c) showing arrested budding particles.
###end p 16
###begin p 17
###xml 248 257 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g001">Figure 1D</xref>
###xml 605 615 605 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s001">Figure S1B</xref>
###xml 1032 1033 1032 1033 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 87 92 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 136 141 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 293 298 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 586 591 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 693 698 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 814 819 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 867 872 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Next, we used transmission electron microscopy (TEM) to visually examine the defect in HIV-1 release caused by over-expression of Alix. HIV-1 was blocked at the plasma membrane where numerous arrested budding structures decorated the cell surface (Figure 1D). Over-expression of Alix arrested HIV-1 budding at various stages but most structures were arrested at early and mid-stages of budding (inset a). We also found aberrant and multi-budded particles (insets b and c) as well as some structures stopped in the late steps of budding (inset c). Similar results were observed with the HIV-1 BH10 strain (Figure S1B). These data suggested that over-expression of Alix led to interference with HIV-1 morphogenesis and budding. Interestingly, although PTAP/Tsg101 is considered to be the primary pathway utilized by HIV-1, over-expression of Alix efficiently decreased HIV-1 release suggesting that the inhibition is due to interference with the function and/or recruitment of a cellular factor common to both the PTAP/Tsg101 and LYPXnL/Alix budding pathways.
###end p 17
###begin title 18
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Over-expression of an N-terminal fragment of Bro1 inhibits HIV-1 release
###end title 18
###begin p 19
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2A</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Munshi1">[65]</xref>
###xml 656 665 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2B</xref>
###xml 773 782 773 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2B</xref>
###xml 1002 1007 1002 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F676D</sub>
###xml 1044 1045 1044 1045 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1074 1079 1074 1079 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F676D</sub>
###xml 1125 1134 1125 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2C</xref>
###xml 1596 1597 1596 1597 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1644 1653 1644 1653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2D</xref>
###xml 1659 1660 1659 1660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1712 1721 1712 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2D</xref>
###xml 1850 1859 1850 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2E</xref>
###xml 126 131 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 580 585 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 956 961 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1110 1115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1289 1294 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1484 1489 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1629 1634 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1835 1840 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We tested fragments of the Alix protein to determine the role of the various domains in the inhibition the protein exerted on HIV-1 release. We first removed the C-terminal PRD to exclude the involvement of the numerous cellular partners known to bind this region, including Tsg101. We then focused on fragments containing the N-terminal Bro1 and the central V domain (Figure 2A) because these domains bind ESCRT-III and Gag, respectively, and were shown to play key roles in Alix function during virus release [44],[47],[60],[65]. Over-expression of Bro1-V efficiently inhibited HIV-1 release but had no detectable effect on Gag accumulation in the cell (Figure 2B). Removal of the N-terminal half of the Bro1 domain reversed the inhibitory effect of the Bro1-V fragment (Figure 2B), implying that binding via the V domain is not sufficient for inhibition in this context. To examine whether the V domain binding to Gag is involved in the Bro1-V block of HIV-1, we next tested the effect of the Bro1-VF676D mutant that no longer binds the LYPXnL motif. We found that Bro1-VF676D retained potent inhibition of HIV-1 release (Figure 2C), indicating that the Gag binding site in the V domain is dispensable for interference with viral exit in this context and suggesting that Bro1-V blocked HIV-1 production via regions located within the Bro1 domain. To map these inhibitory regions, we over-expressed the entire Bro1 domain and found that surprisingly, it had no inhibitory effect on HIV-1. In contrast, expression of a shorter fragment encompassing the first 202 residues of the Bro1 domain (Broi) caused a potent inhibition of HIV-1 release (Figure 2D). Broi had little effect on Gag accumulation in the cell (Figure 2D). These findings identify the N-terminal 202 residues of the Bro1 domain as the region that drives inhibition of HIV-1 release (Figure 2E).
###end p 19
###begin title 20
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The N-terminal region of Bro1 inhibits the release of HIV-1.
###end title 20
###begin p 21
###xml 464 469 464 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F676D</sub>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 506 511 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 554 559 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 604 609 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Schematic representation of constructs used in the experiment. Numbers indicate positions of amino acid residues. (B, C, D) 293T cells were transfected with either pNL4-3 plasmid alone or with increasing amounts of the indicated dominant-negative fragments of Alix. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. (B) Over-expression of Bro1-V but not delBroV inhibited virus-release. (C) The Bro1-VF676D mutant retains inhibitory effect on HIV-1 release. (D) Broi, but not Bro1, inhibits HIV-1 release. (E) Relative release efficiency of HIV-1 virions upon over-expression of each of the four N-terminal fragments of Alix. Error bars indicate the standard deviation from three separate experiments.
###end p 21
###begin title 22
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
Broi inhibits both the PTAP/Tsg101 and LYPXnL/Alix budding pathways
###end title 22
###begin p 23
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 401 410 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g003">Figure 3A</xref>
###xml 497 498 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 535 544 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g003">Figure 3A</xref>
###xml 589 590 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 244 249 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To further examine the nature of the inhibition caused by the dominant negative fragments on HIV-1 release, we over-expressed Broi and Bro1-V with an HIV-1 lacking the LYPXnL motif (pNL4-3 YP-). In absence of the Alix binding site, this mutant HIV-1 relies only on the PTAP/Tsg101 pathway for viral exit. As with wild type pNL4-3, over-expression of delBroV had no effect on the release of NL4-3 YP- (Figure 3A). In contrast, over-expression of the Bro1-V inhibited NL4-3 YP- virus release and Broi exerted the most potent inhibition (Figure 3A). This indicated that over-expression of Broi (and Bro1-V) disrupted a key function in the PTAP/Tsg101 budding pathway.
###end p 23
###begin title 24
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Broi and Bro1-V inhibit HIV-1 release mediated via both Tsg101 and Alix pathways.
###end title 24
###begin p 25
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 359 364 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Inhibition of an HIV-1 mutant lacking the LYPXnL motif. 293T cells were transfected with either pNL4-3 mutant lacking the LYPXnL motif (pNL4-3 YP-) alone or with the indicated dominant-negative fragment of Alix. Pelleted virions and cell lysates were analyzed by western blot using the indicated antibodies. (B) Interference with Alix driven rescue of an HIV-1 mutant lacking the PTAP motif. 293T cells were transfected with either wt pNL4-3 alone, with pNL4-3 mutant lacking the PTAP motif (pNL4-3 PTAP-) alone or with Alix in the presence or absence of the indicated dominant-negative fragment of Alix. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies.
###end p 25
###begin p 26
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 252 253 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 628 629 628 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 708 717 708 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g003">Figure 3B</xref>
###xml 787 788 787 788 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 124 129 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 296 298 <span type="species:ncbi:103820">NC</span>
###xml 688 693 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 836 841 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To examine the effect of Broi and Bro1-V on HIV-1 release driven via the LYPXnL/Alix pathway, we used the budding defective HIV-1 PTAP- mutant. Over-expression of Alix has been shown to rescue the release of this mutant virus by acting through the LYPXnL motif [44],[47]. We reasoned that if the NC-Bro1 interaction is involved in the Alix-driven pathway as was recently suggested [60], Broi and Bro1-V might act as dominant negative fragments and interfere with the ability of Alix to rescue the PTAP- mutant. We tested this hypothesis by over-expressing Alix alone or with either fragment and found that in the presence of Broi or Bro1-V, Alix failed to rescue budding of the defective HIV-1 PTAP- mutant (Figure 3B, compare lanes 4, 5, and 6). Together these results indicate that Broi and Bro1-V exert a global inhibitory effect on HIV-1 budding and release.
###end p 26
###begin title 27
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 4 6 <span type="species:ncbi:103820">NC</span>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The NC domain of HIV-1 Gag is the primary target for Broi inhibition
###end title 27
###begin p 28
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 252 261 252 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4A</xref>
###xml 382 383 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 439 448 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4A</xref>
###xml 551 552 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 619 627 611 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 691 700 683 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4B</xref>
###xml 861 865 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 241 246 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 498 503 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 657 659 <span type="species:ncbi:103820">NC</span>
###xml 956 961 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The results above indicated that Broi efficiently interfered with HIV-1 release, prompting the question as to whether Broi interacts directly with Gag. To examine this, Alix, Bro1, Broi and PRD were tested for their ability to interact with HIV-1 Gag (Figure 4A, left panel) and a GagDeltap6 mutant (right panel) in immunoprecipitation assays. In contrast to PRD, Alix, Bro1 and Broi efficiently pulled-down Gag and the GagDeltap6 mutant (Figure 4A). This demonstrated that in the cell, Bro1 binds HIV-1 Gag in a p6-independent manner and that the Broi region is sufficient for this interaction. Further examination by in vitro pull-down assays showed that NC binds the Bro1 domain of Alix (Figure 4B). These data confirmed that Alix contains a novel binding site for Gag located within Bro1, which is in agreement with the recent findings of Popov et al, 2008 [60]. Our results identify the first 202 residues of the Bro1 domain as sufficient for binding HIV-1 Gag.
###end p 28
###begin title 29
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 4 6 <span type="species:ncbi:103820">NC</span>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The NC domain of HIV-1 Gag is the primary target for Broi inhibition.
###end title 29
###begin p 30
###xml 7 8 7 8 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 231 232 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 510 518 506 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 562 568 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 869 870 865 866 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1002 1003 998 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1134 1135 1130 1131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1271 1272 1267 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 507 509 <span type="species:ncbi:103820">NC</span>
###xml 532 534 <span type="species:ncbi:103820">NC</span>
###xml 562 568 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 1163 1168 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1216 1221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Broi and HIV-1 Gag co-immunoprecipitate in 293T cell lysates. 293T cells were co-transfected with either Gag-Pol (left panel) or GagDeltap6-Pol (right panel) constructs along with expression vectors for HA-Alix, HA-Bro1, HA-Broi, or HA-PRD. Cells were lysed in RIPA buffer and clear lysates were incubated with anti-HA antibody-conjugated beads. Both input and immunoprecipitated complexes were ran on SDS-PAGE for western blot analysis using the indicated antibodies. (B) The Bro1 domain of Alix binds NC in vitro. MBP and MBP-NC proteins were expressed in E.coli, immobilized on amylose resin and incubated with lysates from 293T cells expressing HA-Bro1. Captured Bro1 was detected with anti-HA antibody and MBP proteins were visualized by Coomassie blue staining. (C) The release of NL4-3 DelNC/PR- but not NL4-3 PR- is insensitive to the over-expression of Broi. 293T cells were transfected with either pNL4-3 DelNC/PR- (Left panel) or pNL4-3 PR- (right panel) in presence or absence of HA-Broi. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. (D) Alix but not Broi co-immunoprecipitated with HIV-1 Gag DelNC. 293T cells were co-transfected with HIV-1 Gag DelNC/PR- along with either HA-Alix or HA-Broi. Cells were lysed in RIPA buffer and clear lysates were incubated with anti-HA antibody-conjugated beads. Both input and immunoprecipitated complexes were ran on SDS-PAGE for western blot analysis using the indicated antibodies.
###end p 30
###begin p 31
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 393 397 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 421 422 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 483 504 483 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4C, left panel</xref>
###xml 594 616 594 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4C, right panel</xref>
###xml 665 666 665 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 710 711 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4D</xref>
###xml 849 850 849 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 891 894 891 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 53 55 <span type="species:ncbi:103820">NC</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 156 158 <span type="species:ncbi:103820">NC</span>
###xml 221 226 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 246 248 <span type="species:ncbi:103820">NC</span>
###xml 274 279 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 459 464 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 550 555 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 583 585 <span type="species:ncbi:103820">NC</span>
###xml 633 635 <span type="species:ncbi:103820">NC</span>
###xml 865 870 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 895 897 <span type="species:ncbi:103820">NC</span>
Because the new Alix-Gag interaction is mediated via NC [60], we next examined whether the observed Broi interference with HIV-1 release occurs through the NC domain of Gag. For this, we assessed the effect of Broi on an HIV-1 mutant lacking the NC domain [62]. We used the HIV-1 DelNC/PR- mutant that recovered the ability to release viral particles because the protease (PR) was inactivated [62]. Over-expression of Broi had little effect on the release of HIV-1 DelNC/PR- mutant (Figure 4C, left panel), but retained a potent inhibitory effect on HIV-1 PR- that carries an intact NC domain (Figure 4C, right panel), implying that NC is the primary target for Broi inhibition. In support of this finding, Broi failed to immunoprecipitate the mutant DelNC Gag, which retained binding to full length Alix (Figure 4D). These results indicate that Broi inhibition of HIV-1 release is mediated via NC.
###end p 31
###begin title 32
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Gag recruitment of Broi to the plasma membrane inhibits HIV-1 budding
###end title 32
###begin p 33
###xml 9 10 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 76 85 76 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vis-&#224;-vis</italic>
###xml 150 151 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 240 249 240 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g005">Figure 5A</xref>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 412 421 412 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g005">Figure 5A</xref>
###xml 487 488 487 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 304 309 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 465 470 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Since Broi interacts with Gag, we examined the cellular localization of Broivis-a-vis HIV-1 Gag. Using confocal microscopy analysis, we found that Broi displayed a diffuse cytoplasmic distribution and localized to intracytoplamic vacuoles (Figure 5A). We next examined the localization of Broi vis-a-vis HIV-1 Gag in the cell and found that both proteins displayed a clear colocalization at the plasma membrane (Figure 5A, lower panels). This result indicated that HIV-1 Gag recruits Broi to the plasma membrane.
###end p 33
###begin title 34
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Broi is recruited by Gag to the plasma membrane and interferes with HIV-1 budding.
###end title 34
###begin p 35
###xml 61 62 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 592 593 592 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 743 744 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 339 344 <span type="species:ncbi:10090">mouse</span>
###xml 406 411 <span type="species:ncbi:10090">mouse</span>
###xml 954 959 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) First two upper left panels show a cell expressing HA-Broi (white). The next panel shows a reconstructed 3D view of a stack of Z sections from a cell expressing HA-Broi and Gag-GFP. Lower panels show a single Z section of the same cell showing colocalization of Broi and Gag-GFP at the plasma membrane. Broi (white) was stained with a mouse monoclonal anti-HA antibody and an Alexa 633-conjugated anti-mouse antibody. Nuclei were counterstained with DAPI (blue). F-actin was stained with Alexa 568-conjugated phalloidin (red) to delineate cells. The colocalization channel (yellow) of Broi and Gag-GFP was built using Imaris software. Scale bar = 5 microm. (B, C) Electron micrographs of 293T cells co-transfected with pNL4-3 wt and HA-Broi. (B) Arrested budding structures are indicated with black arrows. Two regions of interest in (a) and (b) show budding structures carrying electron-dense crescent-shaped material at a higher magnification. (C) HIV-1 budding structures tethered to the plasma membrane.
###end p 35
###begin p 36
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 335 353 335 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g005">Figure 5B, a and b</xref>
###xml 525 534 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g005">Figure 5C</xref>
###xml 539 549 539 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s002">Figure S2A</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Demirov2">[23]</xref>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Munshi1">[65]</xref>
###xml 743 744 743 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 162 167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 779 784 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
After establishing that HIV-1 Gag and Broi co-immunoprecipitated in the cell and colocalized at the plasma membrane, we sought to visualize the effect of Broi on HIV-1 morphogenesis and release from the cell using TEM. The over-expression of Broi led to the accumulation of multiple arrested budding structures at the plasma membrane (Figure 5B, a and b). We captured numerous crescent shaped particles, emerging outward to bud from the cytoplasm and aberrant, multi-budded structures that were tethered to the cell surface (Figure 5C and Figure S2A). The arrested budding particles appeared similar to those observed following the over-expression of a dominant negative version of Tsg101 [23] or Alix [65]. These findings demonstrate that Broi over-expression potently inhibits HIV-1 budding.
###end p 36
###begin title 37
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Over-expression of Broi causes the formation of Class E compartments
###end title 37
###begin p 38
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 115 116 115 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 397 398 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 528 536 528 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g005">Figure 5</xref>
###xml 541 549 541 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g006">Figure 6</xref>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g006">Figure 6A</xref>
###xml 695 696 695 696 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 745 754 745 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g006">Figure 6A</xref>
###xml 864 865 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 963 964 963 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1091 1100 1091 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g006">Figure 6A</xref>
###xml 1147 1148 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1233 1234 1233 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1371 1372 1371 1372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1538 1542 1538 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Garrus1">[16]</xref>
###xml 1583 1584 1583 1584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1614 1622 1614 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2</xref>
###xml 1671 1680 1671 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g006">Figure 6B</xref>
###xml 1719 1720 1719 1720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 74 76 <span type="species:ncbi:103820">NC</span>
###xml 223 228 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 256 261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1270 1275 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1428 1434 <span type="species:ncbi:10090">Murine</span>
###xml 1724 1729 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Broi over-expression exerted a potent inhibition on HIV-1 budding via the NC domain in Gag. This suggested that Broi binding interfered with p6 recruitment of one or multiple members of the ESCRT machinery that function in HIV-1 budding and release. Since HIV-1 release and MVB inward budding both require the recruitment of members of the same machinery for membrane fission, we asked whether Broi is recruited to endosomal compartments and interferes with MVB vesicle formation. Broi displayed a diffuse cytoplasmic staining (Figure 5 and Figure 6). In addition, Broi also accumulated in large intracytoplamic vacuoles reminiscent of enlarged endosomal vacuoles (Figure 6A). Interestingly, Broi associated with the membrane of these vacuoles (Figure 6A, inset). To check whether these intracytoplasmic vacuoles were aberrant Class E compartments, we examined Broi localization in presence of the AAA-type ATPase VPS4a, which is a key player in MVB function. Broi affected the intracellular distribution of VPS 4a protein and caused it to accumulate in the enlarged endosomal compartments (Figure 6A, lower panels). This result indicates that Broi over-expression caused the formation of class E compartments. To examine whether Broi-mediated inhibition is specific to HIV-1 and not due to a general toxicity that adversely affected the cell, we tested the impact of Broi and Alix over-expression on the release of the Moloney Murine Leukemia Virus (MoMLV), a gammaretrovirus that requires ESCRT proteins but not Tsg101 for viral egress [16]. Expression of increasing amounts of Broi (comparable to those used in Figure 2) or Alix had no effect on the release of MoMLV (Figure 6B), demonstrating that the effect of Broi on HIV-1 release is specific.
###end p 38
###begin title 39
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Over-expression of Broi causes the formation of Class E compartments but has no effect on MoMLV release.
###end title 39
###begin p 40
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 175 176 175 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 397 398 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 588 589 588 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 685 686 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 796 797 792 793 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 418 423 <span type="species:ncbi:10090">mouse</span>
###xml 485 490 <span type="species:ncbi:10090">mouse</span>
(A) The two upper left panels show a Z section of a cell expressing HA-Broi (white). Inset shows, at a higher magnification, an area of the cell (white rectangle) where HA-Broi associated with membranes of intracytoplasmic vacuoles. The two upper right panels show a Z section of a cell expressing GFP-VPS4a (green). Lower panels show Z sections of cells expressing both HA-Broi and GFP-VPS4a. Broi was stained with a mouse monoclonal anti-HA antibody and an Alexa 633-conjugated anti-mouse antibody. Nuclei were counterstained with DAPI (blue). The colocalization channel (yellow) of Broi and GFP-VPS4a was built using Imaris software. Scale bar = 5 microm. (B) Over-expression of Broi does not inhibit the release of MoMLV. 293T cells were transfected with either pNCA plasmid alone or with Broi and Alix. Pelleted virions and cell lysates were analyzed by western blot using the indicated antibodies.
###end p 40
###begin p 41
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 437 438 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kim1">[46]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami1">[47]</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-McCullough1">[66]</xref>
###xml 561 585 561 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s003">Figure S3A, S3B, and S3C</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ichioka1">[67]</xref>
###xml 695 705 695 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s003">Figure S3D</xref>
###xml 728 729 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 836 837 836 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 774 779 <span type="species:ncbi:4932">yeast</span>
###xml 856 861 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Bro1 domain of Alix binds CHMP4 isoforms, the ESCRT-III components that have been shown to be essential for HIV-1 budding and release [44],[47]. We hypothesized that Broi might have interfered with CHMP4 recruitment to Gag by titration of the available pool of CHMP4 proteins in the cytoplasm. To test this hypothesis, we examined the ability of Broi to bind the three isoforms of CHMP4 using immunoprecipitation assays. Although Broi carries part of the CHMP4 binding interface [44],[46],[47],[66], it was unable to interact with the three CHMP4 isoforms (Figure S3A, S3B, and S3C), even though it retained binding to MAP/RabGAPLP, a known cellular partner of the Bro1 domain of Alix [67] (Figure S3D). The inability of Broi to bind CHMP4 isoforms was also observed in yeast two hybrid assays (data not shown). We conclude that Broi interference with HIV-1 budding is not due to the titration of CHMP4 proteins.
###end p 41
###begin title 42
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Over-expression of Bro1-V inhibits HIV-1 budding in a CHMP4-dependent manner
###end title 42
###begin p 43
###xml 122 127 122 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F676D</sub>
###xml 396 401 396 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 508 513 508 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 563 572 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g007">Figure 7A</xref>
###xml 752 757 752 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 803 812 803 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g007">Figure 7B</xref>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 186 191 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 247 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 487 492 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 548 553 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 611 616 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 992 994 <span type="species:ncbi:103820">NC</span>
###xml 1040 1045 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1087 1089 <span type="species:ncbi:103820">NC</span>
Over-expression of Bro1-V caused inhibition of HIV-1 release. Moreover, mutation of the Gag binding site in Bro1-V (Bro1-VF676D) had no effect on the ability of this fragment to inhibit HIV-1 release, confirming that Bro1-V interference with HIV-1 release is primarily mediated via the Bro1 domain. To address whether this inhibition is related to Bro1 recruitment of CHMP4, we constructed Bro1-VI212D, a mutant that has lost the ability to bind CHMP4 isoforms, and tested its effect on HIV-1 release. Bro1-VI212D mutant had little to no effect on HIV-1 release (Figure 7A) indicating that Bro1-V inhibition of HIV-1 production required an intact CHMP4 binding site in Bro1. Surprisingly, whereas Bro1-V strongly bound Gag missing the p6 domain, Bro1-VI212D lost the ability to bind this truncated Gag (Figure 7B), while retaining binding to full length Gag (data not shown). These results demonstrated that the mutation of the CHMP4 binding site in Bro1 affected its ability to bind Gag via NC but not p6 and that the Bro1-V inhibition of HIV-1 release is due to the binding of Bro1 to NC and requires an intact CHMP4 binding site.
###end p 43
###begin title 44
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Over-expression of Bro1-V inhibits HIV-1 budding in a CHMP4-dependent manner.
###end title 44
###begin p 45
###xml 334 339 334 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 499 504 491 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 367 372 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 937 942 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) The inhibitory effect of Bro1-V is dependent on its CHMP4 binding site. 293T cells were transfected with either pNL4-3 plasmid alone or with increasing amounts of the indicated mutants of Bro1-V. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. (B) Bro1-V but not Bro1-VI212D co-immunoprecipitates with HIV-1 GagDeltap6. 293T cells were co-transfected with GagDeltap6-Pol along with expression vectors for HA-Alix, HA-Bro1-V, HA-Bro1-VI212D and HA-PRD. Cells were lysed in RIPA buffer and clear lysates were incubated with anti-HA antibody-conjugated beads. Both input and immunoprecipitated complexes were ran on SDS-PAGE for western blot analysis using the indicated antibodies. (C-D) Electron micrographs of 293T cells co-transfected with pNL4-3 wt and HA-Bro1-V. (C) The black boxes indicate two regions of interest shown in (a) and (b) at a greater magnification. (D) HIV-1 arrested budding structures. Arrows indicate the electron-dense "ring-like" structure visible at the budding neck of arrested particles.
###end p 45
###begin p 46
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g007">Figure 7C</xref>
###xml 897 906 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g007">Figure 7D</xref>
###xml 911 921 911 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s002">Figure S2B</xref>
###xml 1008 1012 1008 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 181 186 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 509 514 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1071 1076 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1131 1133 <span type="species:ncbi:103820">NC</span>
To visualize the Bro1-V effect on virus release, we examined HIV-1 release in cells expressing Bro1-V by TEM. This analysis showed multiple cells carrying a high number of arrested HIV-1 budding structures that decorated the cell surface. Because the majority of the arrested particles displayed an early budding phenotype, viral morphogenesis was examined at time 32 and 48 hours post-transfection to evaluate the inhibition caused by Bro1-V overtime. At both time points, over-expression of Bro1-V impaired HIV-1 budding, allowing the capture of nascent particles carrying crescent shaped electron-dense material (Figure 7C). Arrested budding structures that remained attached to the plasma membrane and displayed an aberrant morphology were also observed. Remarkably, at 48 h, some of these structures showed a "ring-like" structure or a filament surrounding the budding neck of the particles (Figure 7D and Figure S2B), that is reminiscent of those caused by dominant negative variants of ESCRT proteins [21]. Together these data indicate that Bro1-V interferes with HIV-1 budding, and that this inhibition requires binding to NC and an intact CHMP4 binding site.
###end p 46
###begin title 47
###xml 59 61 <span type="species:ncbi:103820">NC</span>
The Bro1 domain of Alix links Gag to ESCRT-III members via NC
###end title 47
###begin p 48
###xml 97 105 97 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4</xref>
###xml 190 198 190 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g002">Figure 2</xref>
###xml 277 287 277 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s005">Figure S5D</xref>
###xml 611 612 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 718 719 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 747 756 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8A</xref>
###xml 921 930 921 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8A</xref>
###xml 1058 1067 1058 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8A</xref>
###xml 183 188 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 258 263 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 509 514 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 679 684 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our studies demonstrated that Gag recruited Alix via its Bro1 domain in a p6 independent manner (Figure 4). In addition, we found that over-expression of Bro1 caused no inhibition of HIV-1 (Figure 2). In fact, expression of higher amounts of Bro1 stimulated HIV-1 release (See Figure S5D). This suggested that Bro1 binding to Gag might be sufficient to mediate L domain function. Consistent with this hypothesis we found that, like Alix, over-expression of the isolated Bro1 domain rescued the release of the HIV-1 PTAP- defective mutant (data not shown). This rescue was independent of the presence of the LYPXnL motif in p6 since Bro1 over-expression rescued the release of an HIV-1 mutant lacking both PTAP and LYPXnL motifs (NL4-3 PTAP-/YP-) (Figure 8A). Bro1 over-expression also corrected the typical processing defect associated with L domain impairment, as seen by further maturation of p25CA into p24CA product (Figure 8A, see darker exposure of this panel). In contrast, Alix rescue of the L domain defective double mutant was nearly undetectable (Figure 8A).
###end p 48
###begin title 49
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 51 53 <span type="species:ncbi:103820">NC</span>
The Bro1 domain of Alix links Gag to ESCRT-III via NC.
###end title 49
###begin p 50
###xml 1036 1041 1036 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 490 492 <span type="species:ncbi:103820">NC</span>
###xml 599 601 <span type="species:ncbi:103820">NC</span>
(A) The isolated Bro1 domain, but not the full-length Alix, rescues the release of the NL4-3 PTAP-/YP- virus. 293T cells were transfected with either pNL4-3 PTAP-/YP- plasmid alone or with HA-Bro1 or HA-Alix. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. The asterisk indicates a longer exposure showing details of p24/p25 processing in the cells. (B) The rescue of the NL4-3 PTAP-/YP- double mutant virus depends on an intact NC domain in Gag. HA-Bro1 was co-expressed in 293T cells with either pNL4-3 DelNC PTAP-/YP-/PR-, which lacks NC (DelNC) and carries an inactive viral protease (PR-) (lane 4) or pNL4-3 PTAP-/YP- (lane 6) as a control. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. (C) The rescue of NL4-3 PTAP-/YP- release by Bro1 requires an intact CHMP4 binding site. 293T cells were transfected with either pNL4-3 PTAP-/YP- plasmid alone or with increasing amounts of HA-Bro1 (lanes 3-4) or HA-Bro1I212D mutant (lanes 5-6). Pelleted virions and cell lysates were analyzed by western blot using the indicated antibodies.
###end p 50
###begin p 51
###xml 300 301 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8B</xref>
###xml 516 525 516 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8B</xref>
###xml 683 688 683 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 810 815 810 815 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 883 892 883 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8C</xref>
###xml 977 986 977 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9B</xref>
###xml 1249 1250 1249 1250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 86 88 <span type="species:ncbi:103820">NC</span>
###xml 199 201 <span type="species:ncbi:103820">NC</span>
###xml 583 585 <span type="species:ncbi:103820">NC</span>
###xml 635 637 <span type="species:ncbi:103820">NC</span>
###xml 775 780 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 862 867 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1055 1057 <span type="species:ncbi:103820">NC</span>
###xml 1123 1128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1188 1193 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To examine whether the rescue of the HIV-1 double mutant by Bro1 was mediated via the NC domain in Gag, we performed the Bro1 rescue assay with either NL4-3 PTAP-/YP- or with NL4-3 PTAP-/YP- lacking NC (DelNC) and carrying an inactive protease (PR-). We first showed that alterations of PTAP and LYPXnL motifs in the DelNC/PR- virus ablated release (Figure 8B, lane 3), demonstrating that this virus requires L domains to exit the cell. Over-expression of Bro1 failed to rescue the NL4-3 PTAP-/YP- DelNC/PR- mutant (Figure 8B) indicating that Bro1-mediated rescue required an intact NC domain in Gag. To verify whether Bro1 binding to NC recruited CHMP4 proteins, we next tested Bro1I212D, a Bro1 mutant carrying a disrupted CHMP4 binding site, for its ability to rescue the HIV-1 PTAP-/YP- double mutant. Bro1I212D failed to rescue the release of the defective HIV-1 double mutant (Figure 8C) although this fragment retained binding to Gag and was found incorporated in VLPs (Figure 9B and data not shown). These results demonstrate that Bro1 binding to NC links Gag directly to the CHMP4 proteins, which are required for HIV-1 release. The data also show that Bro1 alone can facilitate HIV-1 release in the absence of L domain motifs PTAP and LYPXnL, indicating that the Bro1 domain is the smallest functional unit of Alix.
###end p 51
###begin title 52
###xml 22 24 <span type="species:ncbi:103820">NC</span>
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mapping of regions in NC important for HIV-1 release.
###end title 52
###begin p 53
###xml 32 34 <span type="species:ncbi:103820">NC</span>
###xml 359 361 <span type="species:ncbi:103820">NC</span>
###xml 394 399 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) Schematic representation of NC residues (1-55) with the two zinc fingers (Zf). Cysteine residues (C) changed to serine in the 2Zf- mutant are circled whereas arginine and lysine residues (R, K) were substituted to alanine in RKI (K3 to K26) and RKII (K26 to K52) mutants are underlined. (B, C) Zinc fingers and basic residues in the N-terminal portion of NC are necessary for the rescue of HIV-1 PTAP-/YP- (here named PY-) release by Bro1. (B) 293T cells were transfected with either pNL4-3 2Zf-, which carries disrupted zinc fingers (lane 1), or pNL4-3 2Zf-/PY- (lanes 2-3). pNL4-3 PY- is used (lanes 4-5) as a control for Bro1 rescue. In lane 3, co-transfection with pNL4-3 2Zf-/PY- and HA-Bro1 partially rescues viral release. (C) 293T cells were transfected with either pNL4-3 RKI (lanes 1-3) or pNL4-3 RKII (lanes 4-6) carrying either wt p6 (lanes 1 and 4) or a (PY-) p6 (lanes 2-3 and 5-6) and HA-Bro1 to examine the ability of Bro1 to rescue viral release. The asterisk indicates a longer exposure showing p24/p25 doublets in cell extracts. (D, E) Release defect of 2Zf-, RKI, RKII mutants is rescued by over-expression of Nedd4.2s. (D) 293T cells were transfected either with pNL4-3 (lane 1) or 2Zf-, RKI, RKII, and PTAP- mutant constructs (lanes 2-5). (E) 293T cells were transfected with either 2Zf-, RKI, RKII (lanes 1, 4 and 7) or their (PY-) mutant counterparts alone (lanes 2, 5, and 8) or with Nedd4.2s (lanes 3, 6, and 9). Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies.
###end p 53
###begin p 54
###xml 117 126 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8A</xref>
###xml 311 320 311 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g004">Figure 4B</xref>
###xml 412 428 412 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8A and 8B</xref>
###xml 599 608 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8C</xref>
###xml 734 735 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 255 260 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 298 300 <span type="species:ncbi:103820">NC</span>
###xml 363 368 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 391 393 <span type="species:ncbi:103820">NC</span>
###xml 466 468 <span type="species:ncbi:103820">NC</span>
###xml 489 494 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 537 542 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 557 559 <span type="species:ncbi:103820">NC</span>
###xml 629 631 <span type="species:ncbi:103820">NC</span>
###xml 695 700 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We found that Alix rescue of the double mutant HIV-1 PTAP-/YP- was dramatically weaker in comparison to Bro1 rescue (Figure 8A). Therefore, in the context of full length Alix, binding to Gag via both the Bro1 and V domains is required for its function in HIV-1 release. The finding that Bro1 bound NC directly (Figure 4B) and rescued release of the double mutant HIV-1 PTAP-/YP- virus in an NC-dependent manner (Figure 8A and 8B) is strong evidence for a role of an NC-Bro1 interaction in HIV-1 budding. Bro1 rescue of the double mutant HIV-1 PTAP-/YP- via NC requires an intact CHMP4 binding site (Figure 8C) demonstrating that NC is the site through which a Bro1-CHMP4 complex is recruited by HIV-1 Gag to release virus via the LYPXnL/Alix pathway.
###end p 54
###begin title 55
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Bro1 domain of Alix specifically rescues the release of HIV-1 PTAP-/YP- mutant
###end title 55
###begin p 56
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Kim1">[46]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ichioka2">[68]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ichioka3">[69]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Peck1">[70]</xref>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 529 534 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In the cell, other proteins have been described to carry defined Bro1 domains. To test whether other Bro1-related proteins function in HIV-1 release in a manner similar to Alix, we selected HD-PTP, Rhophilin-2 and Brox, three cellular proteins that share structural similarities with Alix [46],[68],[69],[70]. Although these proteins carry defined Bro1 domains, only the Bro1 domains of HD-PTP and Brox bind CHMP4 proteins. In contrast to Alix, over-expression of HD-PTP, Brox and Rhophilin-2 failed to rescue the release of the HIV-1 PTAP- mutant (data not shown).
###end p 56
###begin p 57
###xml 140 148 140 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g008">Figure 8</xref>
###xml 153 163 153 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s005">Figure S5D</xref>
###xml 222 231 222 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s004">Figure S4</xref>
###xml 393 403 393 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s005">Figure S5A</xref>
###xml 450 460 450 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s005">Figure S5B</xref>
###xml 874 884 874 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000339.s005">Figure S5C</xref>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ichioka2">[68]</xref>
###xml 1146 1150 1146 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Doyotte1">[71]</xref>
###xml 70 75 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 125 130 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 275 280 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 654 659 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 759 764 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 931 933 <span type="species:ncbi:103820">NC</span>
###xml 1043 1048 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1173 1178 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1249 1251 <span type="species:ncbi:103820">NC</span>
###xml 1451 1456 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1533 1538 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Since the isolated Bro1 domain of Alix was able to efficiently rescue HIV-1 release in a p6-independent manner and stimulate HIV-1 release (Figure 8 and Figure S5D), we isolated the Bro1 domains of HD-PTP and Rhophilin-2 (Figure S4) and examined their ability to function in HIV-1 release. We first tested whether the Bro1 domains of HD-PTP and Rhophilin-2, named HDBro1and RhoBro1 hereafter (Figure S5A), bind Gag. Using immunoprecipitation assays (Figure S5B), we found that both domains captured Gag in mammalian cell extracts. We next examined whether this binding alone is sufficient to link Gag to the downstream ESCRT-III machinery and facilitate HIV-1 release. Over-expression of HDBro1, RhoBro1 or Brox (data not shown) did not rescue the release of HIV-1 PTAP-/YP- but actually inhibited Gag processing as little to no p24CA protein was detected in cell extracts (Figure S5C). These results demonstrate that although the NC domain of Gag recognizes other cellular Bro1 domains, only the Bro1 domain of Alix specifically functions in HIV-1 release. The finding that HDBro1 and Brox (data not shown), which also bind CHMP4b proteins [68],[71], failed to rescue the HIV-1 PTAP-/YP- mutant, indicates that the Bro1-CHMP4 complex recruited via NC operates in a context-dependent manner. This result suggests that in addition to the CHMP4 binding site, other regions within the Bro1 domain of Alix are necessary for its function in the release of HIV-1 virions from the cell. Collectively, these data indicate that the rescue of HIV-1 budding defects by the Bro1 domain of Alix is efficient and specific.
###end p 57
###begin title 58
###xml 11 13 <span type="species:ncbi:103820">NC</span>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mapping of NC regions required for Bro1 function in HIV-1 release
###end title 58
###begin p 59
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9A</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Gorelick1">[72]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Guo1">[73]</xref>
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9B</xref>
###xml 67 69 <span type="species:ncbi:103820">NC</span>
###xml 163 165 <span type="species:ncbi:103820">NC</span>
###xml 243 245 <span type="species:ncbi:103820">NC</span>
###xml 484 489 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 540 542 <span type="species:ncbi:103820">NC</span>
###xml 647 649 <span type="species:ncbi:103820">NC</span>
###xml 713 718 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 859 861 <span type="species:ncbi:103820">NC</span>
Recent studies demonstrate that disruption of both zinc fingers in NC inhibits Alix interaction with Gag and facilitation of virus release [60]. To map regions in NC involved in the recruitment of the Bro1 domain of Alix, we used mutations in NC that disrupt both zinc fingers (Figure 9A). In this experiment, the ability of the Bro1 domain of Alix to rescue wild type or the zinc finger mutant (2Zf-) [72],[73] lacking both PTAP and LYPXnL L domains was examined. In contrast to the HIV-1 L domain double mutant (PY-) carrying a wild type NC, the 2Zf- triple mutant was only weakly rescued by Bro1 over-expression (Figure 9B), demonstrating that NC zinc fingers play an important role in Bro1-mediated rescue of HIV-1 release. However, these mutations reduced but did not completely prevent Bro1 from rescuing viral release, suggesting that other regions in NC may be involved in Bro1 recruitment.
###end p 59
###begin p 60
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang1">[63]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 420 429 420 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9A</xref>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 529 538 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9C</xref>
###xml 641 650 641 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9C</xref>
###xml 36 38 <span type="species:ncbi:103820">NC</span>
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 112 117 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 187 189 <span type="species:ncbi:103820">NC</span>
###xml 390 392 <span type="species:ncbi:103820">NC</span>
###xml 712 714 <span type="species:ncbi:103820">NC</span>
###xml 753 758 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 802 804 <span type="species:ncbi:103820">NC</span>
To search for additional regions in NC involved in Bro1 recruitment and function in HIV-1 release, we generated HIV-1 constructs carrying mutations of basic residues scattered throughout NC, because alterations of these residues were previously shown to affect virus release [61],[63],[64]. Substitution of seven lysine and arginine residues in the first (mutant RKI) or the second half of NC (mutant RKII) to alanines (Figure 9A), combined with alterations of the PTAP and LYPXnL motifs led to a complete loss of viral release (Figure 9C). In contrast to RKI mutant however, RKII virus release was rescued with the over-expression of Bro1 (Figure 9C) demonstrating that basic residues in the N-terminal half of NC are required for Bro1 facilitation of HIV-1 release and suggesting that this region of NC is involved in the recruitment of Bro1.
###end p 60
###begin p 61
###xml 166 175 166 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9D</xref>
###xml 495 504 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9D</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Dorfman1">[74]</xref>
###xml 1438 1442 1438 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Chung1">[75]</xref>
###xml 1443 1447 1443 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami2">[76]</xref>
###xml 1537 1538 1537 1538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1548 1557 1548 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9E</xref>
###xml 39 41 <span type="species:ncbi:103820">NC</span>
###xml 400 402 <span type="species:ncbi:103820">NC</span>
###xml 563 565 <span type="species:ncbi:103820">NC</span>
###xml 650 652 <span type="species:ncbi:103820">NC</span>
###xml 740 742 <span type="species:ncbi:103820">NC</span>
###xml 862 864 <span type="species:ncbi:103820">NC</span>
###xml 989 994 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1081 1083 <span type="species:ncbi:103820">NC</span>
###xml 1155 1157 <span type="species:ncbi:103820">NC</span>
###xml 1399 1404 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1435 1437 <span type="species:ncbi:103820">NC</span>
###xml 1590 1592 <span type="species:ncbi:103820">NC</span>
###xml 1624 1629 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1696 1701 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mutations of basic residues throughout NC (mutants RKI and RKII) or in zinc fingers caused a severe decrease in the release of virions carrying an intact PTAP motif (Figure 9D). For this experiment, the level of virus release, as well as Gag processing in the cell, was examined by running protein extracts in conditions that allow good resolution of the p25/24 CA doublet. The pattern obtained with NC mutants RKI and RKII was strikingly similar to that of the PTAP motif mutant virus (PTAP-) (Figure 9D, lanes 3-5). This result indicates that in the context of NC mutants, the PTAP motif is not sufficient to drive virus release, and suggests that NC and the PTAP motif play cooperative roles in viral release. The effect of mutations in NC on virus production was previously attributed to assembly and/or virus budding defects [61],[74]. We hypothesized that NC mutations might interfere with virus budding by preventing the recruitment of cellular components involved in PTAP-mediated HIV-1 release. If this is the case, we reasoned that release defects caused by mutations in NC should be alleviated by recruitment, via regions in Gag outside of the NC domain, of cellular components known to facilitate viral release. In support of this hypothesis, we found that over-expression of Nedd4.2s, an isoform of the E3 ubiquitin ligase Nedd4.2 that was recently shown to stimulate the release of an HIV-1 variant missing L domains and NC [75],[76], efficiently rescued the release of 2Zf-, RKI, and RKII mutants lacking the PTAP and LYPXnL motifs (Figure 9E). This result demonstrates that NC plays a key role in connecting HIV-1 Gag to components of the cellular budding machinery necessary for HIV-1 release.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 692 693 692 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1095 1096 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1175 1176 1175 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1195 1196 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 541 546 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 649 654 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 862 867 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 930 932 <span type="species:ncbi:103820">NC</span>
###xml 967 969 <span type="species:ncbi:103820">NC</span>
###xml 1040 1045 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1116 1121 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1220 1222 <span type="species:ncbi:103820">NC</span>
###xml 1245 1250 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1311 1313 <span type="species:ncbi:103820">NC</span>
###xml 1358 1363 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1404 1409 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1480 1482 <span type="species:ncbi:103820">NC</span>
###xml 1508 1513 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1691 1693 <span type="species:ncbi:103820">NC</span>
###xml 1736 1738 <span type="species:ncbi:103820">NC</span>
###xml 1880 1885 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we find that the over-expression of Alix causes a severe reduction of HIV-1 release. Alix-mediated inhibition is independent of the Gag and Tsg101 binding sites, located within the V and the PRD domains respectively, suggesting that the Bro1 domain is responsible for this inhibition. These results reveal that Bro1 contains a novel binding site for Gag, which is in agreement with data reported by Gottlinger and colleagues [60]. We extend these observations with multiple findings that support a role for the Bro1 domain in HIV-1 budding and release. Specifically, we find that the over-expression of Bro1 rescues the release of an HIV-1 mutant lacking both the PTAP and LYPXnL motifs, and that this rescue provides the first direct evidence that Gag contains a site outside of p6 that mediates virus budding. Importantly, Bro1-driven rescue of HIV-1 release requires the CHMP4 binding site in Bro1 and an intact NC domain in Gag, demonstrating that NC is a novel site that links Gag to the cellular machinery required for HIV-1 release. A dominant negative version of Bro1, Broi, potently inhibits HIV-1 release driven via either the PTAP/Tsg101 or the LYPXnL/Alix pathway. Broi mediated inhibition is NC-dependent and arrests HIV-1 budding at the plasma membrane. Interestingly, mutations in NC that prevent the Bro1-mediated rescue of an HIV-1 lacking both p6-L domains also decrease HIV-1 particle production. Moreover, release defects caused by mutations in NC are corrected by linking HIV-1 to the host budding apparatus via over-expression of Nedd4.2s, a cellular protein that was recently described to link Gag to the ESCRT machinery via interactions outside of the NC and p6 domains. Our studies indicate that NC plays a pivotal role in p6-mediated Late domain functions by controlling the recruitment of the host budding machinery that is necessary for HIV-1 egress.
###end p 63
###begin title 64
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 12 14 <span type="species:ncbi:103820">NC</span>
The role of NC in the LYPXnL/Alix budding pathway
###end title 64
###begin p 65
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 330 331 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 469 472 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 11 13 <span type="species:ncbi:103820">NC</span>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 138 140 <span type="species:ncbi:103820">NC</span>
###xml 268 273 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 493 495 <span type="species:ncbi:103820">NC</span>
###xml 771 776 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A role for NC in HIV-1 budding driven via the LYPXnL/Alix pathway has been recently reported [60]. This new function requires residues in NC believed to interact with the Bro1 domain of Alix. Consistent with this notion, Bro1 is sufficient to rescue the release of an HIV-1 mutant lacking only the PTAP motif or both PTAP and LYPXnL motifs. Because this rescue requires a CHMP4 binding site in Bro1, the results clearly show that Bro1 links Gag to members of ESCRT-III via an interaction with NC, thus identifying Bro1 as the smallest functional unit of Alix. These findings show that, in addition to its known Gag binding site in the V domain, Alix contains a second binding site for Gag located within Bro1 that mediates the recruitment of CHMP4 proteins necessary for HIV-1 separation from the plasma membrane.
###end p 65
###begin p 66
###xml 340 341 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1085 1090 1085 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 1347 1351 1347 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Fisher1">[44]</xref>
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1188 1190 <span type="species:ncbi:103820">NC</span>
###xml 1236 1238 <span type="species:ncbi:103820">NC</span>
###xml 1489 1491 <span type="species:ncbi:103820">NC</span>
In contrast to Bro1, Alix does not efficiently rescue the defective HIV-1 double mutant PTAP-/YP- even though it retains binding to the Gag mutant lacking p6 through the Bro1 domain. Therefore, when expressed in the context of Alix, the Bro1 domain is not sufficient, or not available, to function when the V domain is not bound to the LYPXnL motif, possibly because the V and PRD domains may be masking the functional site within Bro1. Since removal of the V and PRD domains generates a functional Bro1 domain, it is conceivable that the binding of the V domain of Alix to p6 results in conformational changes that reveal functional sites (i.e. CHMP4 binding site) within the Bro1 domain. The functional crosstalk between the Bro1 and V domains is also apparent in the binding properties of the Bro1-V fragment to the p6-deleted Gag. Bro1-V binds Gag in absence of p6 indicating that the interaction is mediated primarily via Bro1. Disruption of the CHMP4 binding site in Bro1-V negatively affects this interaction, although the isolated Bro1 domain carrying the same disruption (Bro1I212D) retains binding to Gag. This suggests that the presence of the V domain weakens Bro1 binding to NC. Therefore, the Bro1 domain interaction with NC is highly influenced by the adjacent V domain, with which it has been shown to form a tight structural unit [44]. Collectively, these observations emphasize the functional and structural interconnection between the Bro1 and the V domains, which bind NC and p6, respectively.
###end p 66
###begin p 67
###xml 197 205 197 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9</xref>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Popov1">[60]</xref>
###xml 1042 1043 1042 1043 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 1059 1069 1059 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g010">Figure 10A</xref>
###xml 50 52 <span type="species:ncbi:103820">NC</span>
###xml 161 166 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 292 294 <span type="species:ncbi:103820">NC</span>
###xml 325 327 <span type="species:ncbi:103820">NC</span>
###xml 395 397 <span type="species:ncbi:103820">NC</span>
###xml 437 439 <span type="species:ncbi:103820">NC</span>
###xml 645 647 <span type="species:ncbi:103820">NC</span>
###xml 737 742 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 831 833 <span type="species:ncbi:103820">NC</span>
###xml 943 945 <span type="species:ncbi:103820">NC</span>
###xml 1016 1021 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our studies indicate that the zinc fingers within NC participate in Bro1 interactions as their disruption decreases the ability of Bro1 to rescue the release of HIV-1 lacking both L domain motifs (Figure 9). However, since Bro1 retained some level of activity in this assay, other regions in NC appear to be involved in Bro1-NC interactions. In fact, our data identify the N-terminal portion of NC as the functional determinant for Bro1-NC interactions, since mutations of basic residues in this region prevented Bro1, and Alix (data not shown), rescue of budding defects. Interestingly, the zinc finger located within the N-terminal portion of NC is also known to play a key role in the Bro1 domain recruitment and Alix facilitation of HIV-1 release [60], suggesting that both the zinc finger and basic residues in this region of NC participate in the recruitment of the Bro1 domain of Alix. These findings identify the N-terminal portion of NC as necessary for the recruitment of Bro1, an essential facilitator of HIV-1 release via the LYPXnL/Alix pathway (Figure 10A).
###end p 67
###begin title 68
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 12 14 <span type="species:ncbi:103820">NC</span>
A model for NC cooperation with the PTAP/Tsg101 and LYPXnL/Alix budding pathways.
###end title 68
###begin p 69
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 12 14 <span type="species:ncbi:103820">NC</span>
###xml 43 45 <span type="species:ncbi:103820">NC</span>
###xml 263 265 <span type="species:ncbi:103820">NC</span>
###xml 320 322 <span type="species:ncbi:103820">NC</span>
###xml 367 372 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 699 701 <span type="species:ncbi:103820">NC</span>
(A) Role of NC in the LYPXnL/Alix pathway: NC interacts with the Bro1 domain of Alix through its N-terminal basic residues and zinc fingers to recruit the essential downstream budding machinery components, ESCRT-III and VPS4, to promote virus egress. (B) Role of NC in the PTAP/Tsg101 pathway: basic residues throughout NC as well as zinc fingers may be required for HIV-1 budding via the PTAP motif, because they participate in the recruitment of members of the cellular budding machinery that include a Bro1-containing protein (Bro1? or Alix) and possible additional host factor(s) (X?) that cooperate with PTAP-bound complexes to facilitate virus release. (+) symbols represent basic residues in NC, (Zf): zinc finger.
###end p 69
###begin title 70
###xml 12 14 <span type="species:ncbi:103820">NC</span>
The role of NC in the PTAP/Tsg101 budding pathway
###end title 70
###begin p 71
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Parent1">[58]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Parent1">[58]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-ShehuXhilaga1">[77]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Parent1">[58]</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-ShehuXhilaga1">[77]</xref>
###xml 1080 1084 1068 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Parent1">[58]</xref>
###xml 1085 1089 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Yuan1">[59]</xref>
###xml 1188 1192 1176 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 1193 1197 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 1198 1202 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 1203 1207 1191 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Accola1">[78]</xref>
###xml 1289 1297 1277 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g009">Figure 9</xref>
###xml 1302 1306 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 1307 1311 1295 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 1312 1316 1300 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang1">[63]</xref>
###xml 1317 1321 1305 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 1545 1549 1533 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 1653 1657 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Gottlinger1">[10]</xref>
###xml 1658 1662 1646 1650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Huang1">[11]</xref>
###xml 1663 1667 1651 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 1668 1672 1656 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 1673 1677 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang1">[63]</xref>
###xml 1678 1682 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 153 158 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 244 <span type="species:ncbi:103820">NC</span>
###xml 290 295 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 365 370 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 614 617 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 635 639 <span type="species:ncbi:11665?1.0">EIAV</span>
###xml 667 672 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 842 847 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 848 850 <span type="species:ncbi:103820">NC</span>
###xml 890 892 <span type="species:ncbi:103820">NC</span>
###xml 991 994 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 1027 1032 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1120 1122 <span type="species:ncbi:103820">NC</span>
###xml 1242 1244 <span type="species:ncbi:103820">NC</span>
###xml 1333 1335 <span type="species:ncbi:103820">NC</span>
###xml 1446 1448 <span type="species:ncbi:103820">NC</span>
###xml 1564 1569 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1582 1584 <span type="species:ncbi:103820">NC</span>
In the current model for HIV-1 budding, the p6-located L domain motif PTAP is considered the primary recruitment site for cellular factors implicated in HIV-1 budding and release. In this study, we present evidence supporting the notion that NC cooperates with the PTAP motif to facilitate HIV-1 release. Interestingly, other studies show that PTAP function within HIV-1 Gag or within heterologous retroviral Gag, depends on its location within the polyprotein [58],[59], suggesting that PTAP might require other regions in Gag to facilitate viral budding and release. When transplanted into the retroviral Gag of RSV [58], MLV [59]or EIAV [77], the PTAP sequence of HIV-1 p6 retains some level of release-driving activity. Notably, in all these Gag chimeras the PTAP motif was either transplanted as part of a sequence that also carries the HIV-1 NC domain [59], or was placed next to the NC domain of the "host" Gag [58],[59],[77]. In contrast, when expressed next to the MA domain within RSV or MoMLV Gag, the PTAP motif of HIV-1 rescues only approximately30% of virus release [58],[59]. Additionally, replacement of NC with a leucine zipper causes a severe reduction in virus release [61],[62],[64],[78]. In fact deletion or mutations in NC cause a severe inhibition of virus release (Figure 9 and [61],[62],[63],[64]), although NC-mutated Gag proteins carry intact L domains and retain the ability to assemble particles. Interestingly, both NC and the PTAP motif are required for efficient budding in the context of a minimal Gag construct [20]. Thus, within HIV-1 Gag neither NC nor the PTAP motif is individually sufficient to mediate virus exit [10],[11],[61],[62],[63],[64], suggesting that their functions are inter-dependent.
###end p 71
###begin p 72
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 448 449 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 734 735 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 767 768 767 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 932 933 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1321 1325 1321 1325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-MartinSerrano2">[19]</xref>
###xml 1326 1330 1326 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 1336 1340 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Howard1">[51]</xref>
###xml 1341 1345 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Lin1">[52]</xref>
###xml 1346 1350 1346 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Zamborlini1">[53]</xref>
###xml 1370 1371 1370 1371 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1533 1537 1533 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Doyotte2">[79]</xref>
###xml 1585 1589 1585 1589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Garrus1">[16]</xref>
###xml 1602 1603 1602 1603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1655 1656 1655 1656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 1878 1879 1878 1879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 16 18 <span type="species:ncbi:103820">NC</span>
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 198 203 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 394 399 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 465 470 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 618 620 <span type="species:ncbi:103820">NC</span>
###xml 690 692 <span type="species:ncbi:103820">NC</span>
###xml 834 836 <span type="species:ncbi:103820">NC</span>
###xml 860 865 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 960 965 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1556 1561 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1844 1849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As evidence for NC-PTAP cooperation in HIV-1 release, we find that Broi and Bro1-V, two fragments of Alix that exhibit dominant negative properties, potently inhibit the release of a PTAP-dependent HIV-1. We confirmed that Broi is responsible for the inhibition because removal of the first 202 N-terminal residues (corresponding to Broi) of Bro1-V reverses the fragment's inhibitory effect on HIV-1 release. We show evidence that the effect of Broi is specific to HIV-1 and not due to an indirect or toxic effect on the cell, because it has no inhibitory effect on the release of MoMLV. Additionally, deletion of the NC domain confers resistance to Broi inhibition, demonstrating that the NC domain of Gag is the site targeted by Broi. We therefore interpret the Broi effect on viral release as resulting from an interference with a NC function necessary for HIV-1 budding driven via the PTAP motif. In fact, over-expression of Broi or Bro1-V interferes with HIV-1 budding and release from the plasma membrane as numerous arrested budding structures decorate the cell surface. In addition, Bro1-V causes the appearance of arrested budding structures that carry an electron-dense filament surrounding their budding neck, a phenotype that was previously seen following interference with the function of ESCRT/MVB proteins [19],[20],[21],[51],[52],[53]. Interestingly, Broi over-expression causes the formation of Class E compartments. Similarly, RNAi-depletion of Tsg101 also leads to the formation of aberrant endosomal compartments [79] and inhibition of HIV-1 release, but not MoMLV [16]. Because Broi has no effect on MoMLV release, we propose that Broi inhibition results from an interference with the function/recruitment of components of the cellular budding machinery that specifically cooperates with the PTAP/Tsg101 budding pathway in HIV-1 egress. The finding that Broi is found associated with endosomal membranes, even though it cannot bind CHMP4 proteins suggests that this portion of Alix associates with a cellular factor or factors that function in endosomal compartments.
###end p 72
###begin p 73
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 530 531 530 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Chung1">[75]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Usami2">[76]</xref>
###xml 1288 1292 1288 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Carlton1">[43]</xref>
###xml 44 46 <span type="species:ncbi:103820">NC</span>
###xml 128 130 <span type="species:ncbi:103820">NC</span>
###xml 292 294 <span type="species:ncbi:103820">NC</span>
###xml 336 341 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 386 <span type="species:ncbi:103820">NC</span>
###xml 462 467 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 494 496 <span type="species:ncbi:103820">NC</span>
###xml 581 583 <span type="species:ncbi:103820">NC</span>
###xml 867 869 <span type="species:ncbi:103820">NC</span>
###xml 920 925 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 959 961 <span type="species:ncbi:103820">NC</span>
###xml 1039 1041 <span type="species:ncbi:103820">NC</span>
###xml 1355 1360 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
It is therefore possible that alteration of NC causes an effect similar to that exerted by Broi (or Bro1-V) because both render NC unavailable to recruit a host factor(s) that cooperates with PTAP in order to facilitate virus release. In fact, we find that mutations of basic residues in the NC domain of Gag cause a severe decrease in HIV-1 release. Remarkably, the release of these NC-mutated viruses is rescued by Nedd4.2s, a cellular protein that stimulates HIV-1 release in the absence of NC and L domain motifs PTAP and LYPXnL [75],[76]. These data suggest that mutations in NC inhibit budding by disabling the recruitment of cellular proteins necessary for virus egress, a defect that can be corrected by linking Gag to ESCRT proteins via a parallel pathway (i.e Nedd.4.2s association with Gag). Interestingly, mutations of basic residues in the first half of NC (mutant RKI) also prevent Bro1-mediated rescue of HIV-1 release, demonstrating that this NC-mutant virus lost the ability to interact with Bro1. These data suggest that NC may recruit the Bro1 domain of Alix to cooperate with the PTAP motif and facilitate release. However, Alix has been reported to be dispensable for PTAP function in 293T cells because PTAP retains activity when Alix is RNAi-depleted from the cell [43]. These observations raise the possibility that in 293T cells, HIV-1 may compensate for the lack of Alix by recruiting other cellular Bro1 domain-containing proteins.
###end p 73
###begin p 74
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Cimarelli1">[61]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang1">[63]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Wang2">[64]</xref>
###xml 589 599 589 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000339-g010">Figure 10B</xref>
###xml 12 14 <span type="species:ncbi:103820">NC</span>
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 201 203 <span type="species:ncbi:103820">NC</span>
###xml 335 337 <span type="species:ncbi:103820">NC</span>
###xml 574 579 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of NC in HIV-1 release appears to be quite complicated, and is not limited to the recruitment of Alix, since the release defect caused by mutations of basic residues in the C-terminal half of NC (mutant RKII) (this study, [61],[63],[64]), can be rescued by Bro1, as well as Nedd4.2s. Our findings suggest a model in which the NC domain recruits a cellular Bro1-containing protein (s) via its N-terminal region, and possibly an additional cellular factor(s) through its C-terminal portion, which cooperate with the PTAP motif in the adjacent p6 domain to facilitate HIV-1 release (Figure 10B).
###end p 74
###begin p 75
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sub>
###xml 82 84 <span type="species:ncbi:103820">NC</span>
###xml 171 176 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 203 205 <span type="species:ncbi:103820">NC</span>
###xml 335 340 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 391 396 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 481 483 <span type="species:ncbi:103820">NC</span>
###xml 518 523 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 615 617 <span type="species:ncbi:103820">NC</span>
###xml 769 771 <span type="species:ncbi:103820">NC</span>
###xml 775 780 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In summary, our studies present evidence strongly supporting a model in which the NC domain of Gag cooperates with L domain motifs in the adjacent p6 domain to facilitate HIV-1 release. We find that the NC domain of Gag is the site that interacts with the Bro1 domain of Alix to recruit ESCRT-III CHMP4 proteins that are necessary for HIV-1 release, thus providing a more complete model for HIV-1 budding mediated via the LYPXnL/Alix pathway. Additionally, we demonstrate that the NC domain of Gag plays a key role in HIV-1 release via the PTAP/Tsg101 pathway. However, although our findings favor a model in which NC promotes viral release by recruiting a Bro1-containing protein, and possibly additional host factors, more detailed mechanistic studies of the role of NC in HIV-1 budding are clearly warranted.
###end p 75
###begin title 76
Materials and Methods
###end title 76
###begin title 77
Proviral constructs
###end title 77
###begin p 78
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Huang1">[11]</xref>
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Adachi1">[80]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Ott2">[62]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Guo1">[73]</xref>
###xml 506 508 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sub>
###xml 510 512 510 512 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sub>
###xml 516 518 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sub>
###xml 520 522 520 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sub>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sph</italic>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Age</italic>
###xml 744 746 744 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sub>
###xml 748 750 748 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sub>
###xml 787 790 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pol</italic>
###xml 1032 1035 1032 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sph</italic>
###xml 1037 1040 1037 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Age</italic>
###xml 1754 1761 1748 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 1890 1894 1884 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Colicelli1">[81]</xref>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 243 245 <span type="species:ncbi:103820">NC</span>
###xml 470 472 <span type="species:ncbi:103820">NC</span>
###xml 1318 1320 <span type="species:ncbi:103820">NC</span>
The wild-type (wt) full-length HIV-1 molecular clone pNL4-3 and the mutant pNL4-3 PTAP- (gift from Eric Freed) were previously described [11],[80]. The pNL4-3 DelNC/PR- and pNL4-3 PR- plasmids (both gifts from David Ott) contain a deletion of NC from residue 5 to 52 and/or a G75R mutation in the protease sequence, respectively [62]. The pNL4-3 SSHS/SSHS construct (gift from Robert Gorelick, called 2Zf- in the text) has all cysteine (C) residues of the nucleocapsid (NC) mutated to serine (S) [73]. The 23YP24 to 23LV24 mutation in Gag p6 was introduced by site directed mutagenesis of pNL4-3 wt and pNL4-3 PTAP- using overlap extension PCR. The 5' primers contained either the upstream SphI or the downstream AgeI restriction sites and the 23LV24 mutation, conserving the underlying pol sequence. Upstream fragments amplified from pNL4-3 PTAP- also contained the PTAP to LIRL mutation. Each of the fragments was gel purified, and amplified. The full length "LV or YP-" and "PTAP-/YP-" fragments were gel purified, digested with SphI/AgeI and subcloned back into pNL4-3 using the LONG DNA ligation kit (Takara Bio Inc, Madison, Wisconsin, United States) to make pNL4-3 YP- and pNL4-3 PTAP-/YP-, respectively. The pNL4-3 RK I and RK II plasmids were constructed using the same overlap extension PCR method. In RK I, NC residues K3, R7, R10, K11, K14, K20 and K26 were substituted with alanines. RK II carries alanine substitutions of residues K26, R29, R32, K33, K34, K38, K41, K47 and R52. The PTAP-/YP- mutation in p6 was also introduced in pNL4-3 DelNC/PR-, pNL4-3 2Zf-, pNL4-3 RK I and II by a similar approach, introducing the LIRL and LV mutations simultaneously. All proviral plasmids were grown at 30degreesC and their integrity was checked by HindIII restriction digest and sequencing. Finally, the MoMLV proviral plasmid pNCA, obtained from Steve Goff, was previously described [81].
###end p 78
###begin title 79
Expression vectors
###end title 79
###begin p 80
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Strack1">[20]</xref>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 345 346 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoR</italic>
###xml 575 578 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-vonSchwedler1">[21]</xref>
###xml 778 781 778 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 783 786 783 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 793 796 793 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1100 1103 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 1105 1108 1105 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1224 1228 1224 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-HermidaMatsumoto1">[82]</xref>
###xml 1238 1240 1238 1240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wt</sub>
###xml 1378 1382 1374 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000339-Smith1">[83]</xref>
###xml 1554 1558 1550 1554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 1562 1565 1558 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1758 1761 1754 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1763 1766 1759 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 1870 1873 1866 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1876 1879 1872 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 2071 2075 2067 2071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hind</italic>
###xml 2079 2082 2075 2078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 2262 2265 2258 2261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 2268 2271 2264 2267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 2364 2367 2360 2363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xmn</italic>
###xml 1138 1143 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2108 2110 <span type="species:ncbi:103820">NC</span>
###xml 2160 2162 <span type="species:ncbi:103820">NC</span>
Alix/AIP-1 cDNA was kindly donated by Heinrich Gottlinger [20] and subcloned in pHM6 (Roche, Indianapolis, Indiana, United States) between EcoRI/NotI for an N-terminal HA-tagged Alix. Point mutations were introduced in Alix using the QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, California, United States). Alix fragments Broi (residues 1-202), Bro1 (1-367), Bro1-V (1-702), delBroV (203-702), VPRD (364-868) and PRD (703-868) were generated by PCR amplification from the full-length cDNA templates (wt or mutant) and subcloning into pHM6 using the EcoRI/NotI restriction sites. CHMP4A-DsRed2, CHMP4C-DsRed2, EGFP-VPS4A plasmids were kindly provided by Wesley Sundquist [21]. CHMP4A and CHMP4C genes were amplified and subcloned into p3XFLAG (Sigma) between NotI/BglII and NotI/EcoRI respectively for N-terminally tagged CHMP4A and C. The expression vector for N-terminal FLAG-tagged CHMP4B was purchased from GeneCopoeia (Germantown, Maryland, United States). RabGAPLP/MAP cDNA (clone Image 3027777) was purchased from Open Biosystems and cloned into p3XFLAG plasmid between the NotI/EcoRI sites. The Rev-independent HIV-1 Gag-EGFP construct was kindly provided by Marilyn Resh and described previously [82]. The pGAGwtPOL-RRE-r, pGAGDeltap6POL-RRE-r constructs, as well as the pRev1 plasmid were generous gifts from Carol Carter and were described earlier [83]. HD-PTP (clone Image 6579163) cDNA was purchased from Open Biosystems and amplified to clone the full-length gene and HDBro1 fragment (residues 1-369) in pHM6 between the HindIII/EcoRI sites. Rhophilin-2 (clone Image 4830913) cDNA was purchased from Open Biosystems and amplified to clone the full-length gene and the Rho2Bro1 fragment (residues 107-507) in pHM6 between the KpnI/NotI sites. Brox (clone image 8322687) was obtained from Open Biosystems and subcloned in pHM6 between the EcoRI/NotI sites. Nedd4.2s, which lacks the first 121 residues of Nedd4.2 was amplified from the full-length Nedd4.2 (clone ID 5528964 purchased from Open Biosystems) and subcloned in pHM6 between the HindIII/KpnI sites. Finally, the MBP-NC construct was made by amplification of the whole NC region from pNL4-3 and cloned in pMAL-c2X (NEB, Ipswich, Massachusetts, United States) between the EcoRI/BamHI sites. The MBP control plasmid was constructed by creating a stop codon downstream of the XmnI site of the pMAL-c2X polylinker using site directed mutagenesis. All constructs were checked by restriction digest and sequencing.
###end p 80
###begin title 81
Virus-release analysis
###end title 81
###begin p 82
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 893 898 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
###xml 989 994 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1077 1082 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1468 1472 <span type="species:ncbi:9925">goat</span>
###xml 1526 1531 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
293T cells (2.5x106) were seeded into T-25 flasks and transfected the following day using Lipofectamine 2000 (Invitrogen) according to manufacturer instructions. For dominant negative (DN) experiments, a pNL4.3 to DN DNA ratio ranging from 1:5 to 1:10 was used. The amount of DNA was normalized for each transfection with pHM6 empty plasmid. At 24 h post-transfection, culture supernatants were filtered through 0.45 microm syringe filters and virions were pelleted at 151,000xg for 1 h on a 20% (w/v in PBS) sucrose cushion. The cells were washed once in PBS and lysed in NP-40 lysis buffer (1% [v/v] NP-40, 50 mM Tris pH 8.0, 150 mM NaCl and protease inhibitor cocktail [Complete, Roche]). Resuspended virions and cell lysis supernatants were analyzed by SDS-PAGE on 12.5% or 15% acrylamide gels and transferred to Immobilon-P membranes (Millipore, Billerica, Massachusetts, Unites States). HIV-1 Gag and p24 proteins were detected by immunoblotting using either a mouse monoclonal anti-HIV-1 p24 (NEA-9306, NEN Life Science, Boston, Massachusetts, Unites States) or an anti-HIV-1 p24 monoclonal antibody (clone 183-H12-5C available through the NIH AIDS Research and Reference Reagent Program). Protein expression was detected using a monoclonal anti-HA and anti-alpha-tubulin antibodies (HA-7 and DM 1A, respectively, Sigma, St. Louis, Missouri, United States). The same protocol was used for MoMLV release experiments. MoMLV p65Gag and p30CA were detected using a goat anti-p30CA antibody (generous gift from Steve Goff). HIV-1 virus release efficiency was calculated (at time 24 h post-transfection) as the ratio of virion-associated capsid (p24) to total cellular Gag (p55 + p24) both determined by densitometry analysis of western blot films using ImageJ software (Rasband, W.S., NIH, Bethesda, MD, USA, , 1997-2007). The release efficiency of NL4-3 in presence of Alix and fragments of Alix was compared to the release efficiency of NL4-3 alone which was arbitrarily set at 100%.
###end p 82
###begin title 83
Transmission electron microscopy (TEM)
###end title 83
###begin p 84
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
293T cells were seeded at 6x105/well of a 6-well plate and transfected the following day with pNL4-3 and expression vectors for HA-tagged full-length Alix or fragments using Lipofectamine 2000. At times 32 and 48 h post-transfection, the supernatants were removed and the cells were fixed for 15 min at room temperature in 2% (v/v) glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). The cells were then rinsed in cacodylate buffer and postfixed in 1% (v/v) osmium tetroxide in the same buffer. The samples were subsequently rinsed again in 0.1 N sodium acetate buffer (pH 4.2), stained in 0.5% uranyl acetate (v/v) in the same buffer, dehydrated in graded ethanol, then infiltrated overnight in pure epoxy resin. The wells were embedded in fresh resin the next day and cured at 55degreesC. Blocks were cut from the cured samples and mounted appropriately for ultramicrotomy. Thin sections were stained in uranyl acetate and lead citrate and stabilized by carbon evaporation. Images were obtained with a Hitachi H7600 electron microscope equipped with an AMT XL41M digital camera. Approximately 500 cells were examined for each sample and arrested budding structures attached to the cell as well as released virions were enumerated to determine the release efficiency.
###end p 84
###begin title 85
Immunoprecipitation assays
###end title 85
###begin p 86
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 315 316 312 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 318 319 315 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 448 449 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1016 1017 993 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 926 931 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1313 1316 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1326 1333 <span type="species:ncbi:9606">patient</span>
293T cells (2x106) were seeded into T25 flasks and transfected the following day using Lipofectamine 2000. Forty-eight hours post-transfection, the cells were harvested, washed twice in cold PBS and lysed in RIPA buffer (0.5% NP-40, 50 mM Hepes pH 7.3, 150 mM NaCl, 2 mM EDTA, 20 mM beta-glycerophosphate, 0.1 mM Na3VO4, 1 mM NaF, 1 mM PMSF, 0.5 microM DTT and protease inhibitor cocktail [Complete, Roche]). The lysates were centrifuged at 16,100xg, 4degreesC, for 10 min and supernatants were incubated at 4degreesC with EZview agarose beads covalently attached to either anti-HA or anti-Flag mouse monoclonal antibody (Sigma). The beads were then extensively washed in RIPA buffer prior to 2 successive elutions with the appropriate peptide (100 microg/ml). Immunoprecipitates and cell lysates (input fractions) were analyzed by SDS-PAGE and immunoblotting with anti-HA or anti-FLAG M2 antibodies (Sigma) as indicated. For HIV-1 Gag interaction studies, the same protocol was followed except that 293T cells (6x106) were transfected with various expression vectors for HA-tagged or Flag-tagged proteins along with either pGAGPOL-RRE-r with pRev1, or pNL4-3 DelNCPR- plasmid. Immunoprecipitates and cell lysates (input fraction) were analyzed by SDS-PAGE and immunoblotting with anti-HA antibody (Sigma) and an HIV-positive patient serum.
###end p 86
###begin title 87
Immunofluorescence microscopy
###end title 87
###begin p 88
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
293T cells (1.8x105) were seeded on glass coverslips in 12-well plates and transfected the following day with the indicated expression vectors using Lipofectamine 2000. Twenty-four hours post-transfection, the cells were washed once in PBS, fixed for 10 min with 3.7% paraformaldehyde (EM grade, v/v in PBS), quenched in 100 mM Glycine in PBS, permeabilized with 0.5% (v/v in PBS) Triton X-100 (Sigma) for 2 min and blocked in 1% (v/v in PBS) BSA for 30 min. Primary antibody anti-HA (Sigma HA-7) was applied at 1:5000 in 1% BSA for 1 h followed by an Alexa 633 conjugated secondary anti-mouse antibody (Invitrogen). F-actin was stained with Alexa 568 conjugated Phalloidin and nuclei were counterstained with DAPI 1 microg/ml. Coverslips were mounted with ProLong Gold (Invitrogen) on microscope glass slides and allowed to cure overnight. Sequential Z-sections (about 0.25 microm each) were obtained by confocal microscopy (Leica SP5 confocal microscope, Leica Microsystems, Exton, PA, United States). Raw data were deconvolved with Huygens Essentials software (version 3.1, Scientific Volume Imaging BV, Hilversum, The Netherlands) reconstructed in 3-D and analyzed with Imaris software (version 6.0, Bitplane AG, Zurich, Switzerland) for colocalization statistics.
###end p 88
###begin title 89
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro pull-down assay
###end title 89
###begin p 90
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hsdR</italic>
###xml 0 6 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
###xml 72 74 <span type="species:ncbi:103820">NC</span>
###xml 751 753 <span type="species:ncbi:103820">NC</span>
E.coli TB1 (JM83 hsdR) cells were transformed with the pMAL control and NC plasmids, grown to exponential phase and induced with IPTG for 3 to 4 h. Cells were harvested and lysed in column buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 1 mM DTT, 1 mM PMSF and protease inhibitor cocktail) by sonication. Lysates were cleared by centrifugation and were incubated with amylose resin to allow binding. The resin was washed extensively with column buffer and RIPA buffer. In parallel, 293T cells were transfected with expression vectors for HA-tagged fragments of Alix as described in the Immunoprecipitation assay section. At 48 h post-transfection 293T cells were lysed in RIPA buffer and cleared lysates were incubated with immobilized MBP control or MBP-NC on resin. After extensive washes in RIPA buffer, the resin was boiled in sample buffer and analyzed by SDS-PAGE and western blot using anti-HA antibody or Coomassie blue staining.
###end p 90
###begin title 91
Accession numbers (GenBank) of genes used in this study
###end title 91
###begin p 92
###xml 25 30 <span type="species:ncbi:4932">Yeast</span>
Alix (NM_013374), Bro1p (Yeast U37364), Brox (BC113635), CHMP4A (BC113533), CHMP4B (BC033859), CHMP4C (BC014321), HD-PTP (BC089042), Nedd4.2 (BC032597), RabGAPLP or MAP (NM_015705), Rhophilin-2 (BC036447) and VPS4A (BC047932).
###end p 92
###begin title 93
Supporting Information
###end title 93
###begin p 94
###xml 37 42 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 99 104 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 137 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 540 545 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 661 666 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 699 704 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 815 820 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Alix over-expression interferes with HIV-1 budding. (A) Titration of HA-Alix used in the rescue of HIV-1 PTAP- and inhibition of wt HIV-1. 293T cells were transfected with either pNL4-3 PTAP- (lanes 1-5) or pNL4-3 wt (lanes 6-9) in absence (lanes 1 & 6) or presence of 0.15 microg (lane 2), 0.7 microg (lanes 3 & 7), 1.5 microg (lanes 4 & 8) and 3 microg (lanes 5 & 9) of HA-Alix per million cells. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. Note that the optimal rescue of HIV-1 PTAP- was obtained with 0.6 microg of HA-Alix (lane 3) whereas 3 microg of HA-Alix failed to rescue the release of HIV-1 PTAP- (lane 5) and inhibited wt HIV-1 (lane 9). (B) Transmission Electron Microscopy (TEM) images of thin-sectioned 293T cells transfected with the HIV-1 BH-10 molecular clone, alone (a) or with Alix (b-f) showing arrested budding particles.
###end p 94
###begin p 95
(2.92 MB PDF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Broi and Bro1-V over-expression interfere with HIV-1 budding. Electron micrographs of 293T cells co-transfected with pNL4-3 wt and HA-Broi (A) or Bro1-V (B) showing arrested budding particles. Arrows indicate structures arrested at late budding steps. In the inset labeled (b), an arrested particle carrying an electron-dense "ring-like" structure (arrows) is shown at a higher magnification.
###end p 97
###begin p 98
(3.01 MB PDF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
Broi does not bind CHMP4 isoforms. 293T cells were co-transfected with HA-Alix or Alix fragments and either FLAG-tagged CHMP4A (panel A), CHMP4B (panel B), CHMP4C (panel C), or MAP/RabGAPLP (panel D). Alix and fragments were captured from cell lysates using anti-HA antibody-conjugated beads. All fractions, input and immunoprecipitated, were analyzed by SDS-PAGE and western blot using anti-HA and anti-Flag antibodies as indicated.
###end p 100
###begin p 101
(2.51 MB PDF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:4932">yeast</span>
Alignment of protein sequences of Bro1 domains from five different Bro1-containing proteins. Bro1 domains from the human Alix, HD-PTP, Rhophilin-2, and Brox as well as the yeast Bro1p protein sequences were aligned using the Align X program of the Vector NTI suite. Conserved residues are highlighted in colors.
###end p 103
###begin p 104
(0.14 MB PDF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 551 556 551 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">I212D</sub>
###xml 480 485 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1186 1191 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Bro1 domains of HD-PTP and Rhophilin-2 interact with Gag, but only Alix Bro1 promotes viral budding. (A) Schematic representation of the domain organization of Alix, HD-PTP, and Rhophilin-2 used in this experiment. PRD: Proline Rich Domain, PTP: Protein Tyrosine Phosphatase, PEST: Proline-glutamic acid (E)-Serine-Threonin rich region, RB: Rho Binding domain and PDZ: PS.D.-95, Disc-large, ZO-1 domain. (B) Bro1 domains of Alix, HD-PTP, and Rhophilin-2 co-immunoprecipitate with HIV-1 Gag. 293T cells expressing Gag-Pol alone or with HA-Bro1, HA-Bro1I212D, HA-HDBro1, and HA-RhoBro1 were lysed in RIPA buffer and incubated with anti-HA antibody-conjugated beads. Both input and immunoprecipitated complexes were analyzed by SDS-PAGE and western blot using indicated antibodies. (C) Over-expression of only the Alix Bro1 domain, rescued the release of the NL4-3 PTAP-/YP- virus. 293T cells were transfected with either pNL4-3 PTAP-/YP- plasmid alone or with increasing amounts of HA-Bro1, HA-HDBro1, or HA-RhoBro1. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies. (D) Over-expression of HA-Bro1, but not HA-HDBro1, stimulates HIV-1 release. 293T cells were transfected with either wt pNL4-3 plasmid alone or with increasing amounts of HA-Bro1 or HA-HDBro1. Pelleted virions and cell lysates were analyzed by SDS-PAGE and western blot using the indicated antibodies.
###end p 106
###begin p 107
(5.82 MB PDF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 137 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 142 147 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 239 244 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1032 1037 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We thank Eric Freed (DRP, NCI-Frederick) for the HIV-1 PTAP- mutant; David Ott (AIDS Vaccine Program, SAIC-Frederick) for the DelNC HIV-1 and HIV-1 PR- constructs; Robert Gorelick (AIDS Vaccine Program, SAIC-Frederick) for the zinc finger HIV-1 mutant; Carol Carter (SUNY, Stony Brook) for the Gag-Pol expression vectors; Wes Sundquist and Uta von Schwedler (University of Utah) for CHMP4 and VPS4 expression plasmids; Marilyn Resh (Memorial Sloan-Kettering Cancer Center, NY) for the Gag-GFP construct; Heinrich Gottlinger (University of Massachusetts) for Alix cDNA; Steve Goff for MoMLV reagents; the biological imaging team at the RTB, NIAID, for help with generating the IF images; our colleagues at LMM for generously sharing their insight as this work has evolved; Alicia Buckler-White and Ron Plishka for sequencing; and Alan Rein (DRP, NCI-Frederick), Kuan-Teh Jeang (LMM, NIAID, NIH), Bernard Moss (LVD, NIAID, NIH), and Carol Carter (SUNY, Stony Brook) for helpful discussions and critical reading of the manuscript. The HIV-1 p24 Monoclonal Antibody (183-H12-5C) was obtained from Bruce Chesebro and Kathy Wehrly through the NIH AIDS Research and Reference Reagent Program.
###end p 109
###begin title 110
References
###end title 110
###begin article-title 111
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of myristylation in HIV-1 Gag assembly.
###end article-title 111
###begin article-title 112
###xml 53 83 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.
###end article-title 112
###begin article-title 113
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 gag proteins: diverse functions in the virus life cycle.
###end article-title 114
###begin article-title 115
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The structural biology of HIV assembly.
###end article-title 115
###begin article-title 116
###xml 32 67 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
###end article-title 116
###begin article-title 117
###xml 38 40 <span type="species:ncbi:103820">NC</span>
###xml 55 73 <span type="species:ncbi:11886">Rous sarcoma virus</span>
###xml 78 113 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
###end article-title 117
###begin article-title 118
Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication.
###end article-title 118
###begin article-title 119
###xml 52 80 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.
###end article-title 119
###begin article-title 120
###xml 59 94 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.
###end article-title 120
###begin article-title 121
Late budding domains and host proteins in enveloped virus release.
###end article-title 121
###begin article-title 122
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tsg101: HIV-1's ticket to ride.
###end article-title 122
###begin article-title 123
Retrovirus budding.
###end article-title 123
###begin article-title 124
Retrovirus budding.
###end article-title 124
###begin article-title 125
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
###end article-title 125
###begin article-title 126
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 10 21 <span type="species:ncbi:205488">Ebola virus</span>
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
###end article-title 126
###begin article-title 127
###xml 81 84 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag).
###end article-title 127
###begin article-title 128
Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.
###end article-title 128
###begin article-title 129
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 52 <span type="species:ncbi:11665?1.0">EIAV</span>
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.
###end article-title 129
###begin article-title 130
###xml 23 26 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The Protein Network of HIV Budding.
###end article-title 130
###begin article-title 131
###xml 84 119 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production.
###end article-title 131
###begin article-title 132
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
###end article-title 132
###begin article-title 133
Role of ESCRT-I in retroviral budding.
###end article-title 133
###begin article-title 134
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding.
###end article-title 134
###begin article-title 135
###xml 57 62 <span type="species:ncbi:4932">yeast</span>
Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking.
###end article-title 135
###begin article-title 136
Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I.
###end article-title 136
###begin article-title 137
###xml 60 65 <span type="species:ncbi:4932">Yeast</span>
Molecular Architecture and Functional Model of the Complete Yeast ESCRT-I Heterotetramer.
###end article-title 137
###begin article-title 138
Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting.
###end article-title 138
###begin article-title 139
###xml 32 37 <span type="species:ncbi:4932">yeast</span>
Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p.
###end article-title 139
###begin article-title 140
The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function.
###end article-title 140
###begin article-title 141
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding.
###end article-title 141
###begin article-title 142
###xml 66 71 <span type="species:ncbi:9606">human</span>
Structure and ESCRT-III protein interactions of the MIT domain of human VPS4A.
###end article-title 142
###begin article-title 143
ESCRT-III recognition by VPS4 ATPases.
###end article-title 143
###begin article-title 144
Context-dependent effects of L domains and ubiquitination on viral budding.
###end article-title 144
###begin article-title 145
Structural basis for viral late-domain binding to Alix.
###end article-title 145
###begin article-title 146
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 98 <span type="species:ncbi:11665?1.0">EIAV</span>
Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV.
###end article-title 146
###begin article-title 147
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein.
###end article-title 147
###begin article-title 148
Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2+-dependent reaction.
###end article-title 148
###begin article-title 149
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
ALIX Catches HIV.
###end article-title 149
###begin article-title 150
The multiple personalities of Alix.
###end article-title 150
###begin article-title 151
###xml 76 100 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Bro1 is an endosome-associated protein that functions in the MVB pathway in Saccharomyces cerevisiae.
###end article-title 151
###begin article-title 152
Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery.
###end article-title 152
###begin article-title 153
Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding.
###end article-title 153
###begin article-title 154
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis.
###end article-title 154
###begin article-title 155
Structural basis for endosomal targeting by the Bro1 domain.
###end article-title 155
###begin article-title 156
###xml 17 22 <span type="species:ncbi:9606">Human</span>
Potent Rescue of Human Immunodeficiency Virus Type 1 Late Domain Mutants by ALIX/AIP1 that Depends on its CHMP4 Binding Site.
###end article-title 156
###begin article-title 157
Membrane curvature and mechanisms of dynamic cell membrane remodelling.
###end article-title 157
###begin article-title 158
###xml 69 99 <span type="species:ncbi:11665">equine infectious anemia virus</span>
Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding.
###end article-title 158
###begin article-title 159
Plasma membrane deformation by circular arrays of ESCRT-III protein filaments.
###end article-title 159
###begin article-title 160
CHMP1 functions as a member of a newly defined family of vesicle trafficking proteins.
###end article-title 160
###begin article-title 161
Interaction of the mammalian endosomal sorting complex required for transport (ESCRT) III protein hSnf7-1 with itself, membranes, and the AAA+ ATPase SKD1.
###end article-title 161
###begin article-title 162
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding.
###end article-title 162
###begin article-title 163
###xml 74 85 <span type="species:ncbi:11963">foamy virus</span>
Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.
###end article-title 163
###begin article-title 164
###xml 35 70 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A bipartite late-budding domain in human immunodeficiency virus type 1.
###end article-title 164
###begin article-title 165
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
###end article-title 165
###begin article-title 166
Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.
###end article-title 166
###begin article-title 167
###xml 72 90 <span type="species:ncbi:11886">Rous sarcoma virus</span>
###xml 95 123 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
###end article-title 167
###begin article-title 168
###xml 15 44 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
###end article-title 168
###begin article-title 169
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Immunodeficiency Virus Type 1 Gag Engages the Bro1 Domain of ALIX/AIP1 through Nucleocapsid.
###end article-title 169
###begin article-title 170
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
###end article-title 170
###begin article-title 171
###xml 75 110 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
###end article-title 171
###begin article-title 172
RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes.
###end article-title 172
###begin article-title 173
Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses.
###end article-title 173
###begin article-title 174
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains.
###end article-title 174
###begin article-title 175
###xml 31 36 <span type="species:ncbi:9606">human</span>
ALIX-CHMP4 interactions in the human ESCRT pathway.
###end article-title 175
###begin article-title 176
Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.
###end article-title 176
###begin article-title 177
Brox, a novel farnesylated Bro1 domain-containing protein that associates with charged multivesicular body protein 4 (CHMP4).
###end article-title 177
###begin article-title 178
HD-PTP and Alix share some membrane-traffic related proteins that interact with their Bro1 domains or proline-rich regions.
###end article-title 178
###begin article-title 179
The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization.
###end article-title 179
###begin article-title 180
The Bro1-related protein HD-PTP/PTPN23 is required for endosomal cargo sorting and multivesicular body morphogenesis.
###end article-title 180
###begin article-title 181
###xml 28 63 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
###end article-title 181
###begin article-title 182
###xml 30 65 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer.
###end article-title 182
###begin article-title 183
###xml 78 113 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.
###end article-title 183
###begin article-title 184
###xml 61 96 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains.
###end article-title 184
###begin article-title 185
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase.
###end article-title 185
###begin article-title 186
###xml 36 66 <span type="species:ncbi:11665">equine infectious anemia virus</span>
Late domain-dependent inhibition of equine infectious anemia virus budding.
###end article-title 186
###begin article-title 187
###xml 100 135 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
###end article-title 187
###begin article-title 188
Depletion of TSG101 forms a mammalian "Class E" compartment: a multicisternal early endosome with multiple sorting defects.
###end article-title 188
###begin article-title 189
###xml 74 79 <span type="species:ncbi:9606">human</span>
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
###end article-title 189
###begin article-title 190
###xml 39 68 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
Isolation of an integrated provirus of Moloney murine leukemia virus with long terminal repeats in inverted orientation: integration utilizing two U3 sequences.
###end article-title 190
###begin article-title 191
###xml 16 51 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.
###end article-title 191
###begin article-title 192
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 78 93 <span type="species:ncbi:10633">simian virus 40</span>
Human immunodeficiency virus type 1 Pr55gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles.
###end article-title 192
###begin p 193
The authors have declared that no competing interests exist.
###end p 193
###begin p 194
This work was supported by the Intramural Research Program of the NIH, NIAID (). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 194

